| 2005-03-18 08:39:00 |
Disclosure Document |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d0c0c86b2c3e4449c8a43c1834cec296 |
|
| 2005-03-24 08:41:00 |
Pre-Quotation Disclosure |
1 |
https://app.sharelinktechnologies.com/announcement/asx/67707b53b9cdf6a848fbc196e95fccc6 |
Stock Exchange Announcement - Other
|
| 2005-03-24 08:41:00 |
Distribution Schedule |
0 |
https://app.sharelinktechnologies.com/announcement/asx/562a12e90505b869b8ee3bb7016256c5 |
|
| 2005-03-24 08:41:00 |
Top 20 shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7831b68669f0b65738cd946024187eab |
|
| 2005-03-24 08:41:00 |
Updated statement of commitments |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd833cc0341d1ee668f6f4dcd60d2ede |
|
| 2005-03-24 08:41:00 |
Conversion of Preference Shares to Ordinary Shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f81f4e41169ba0fbae31b6d6fda9213a |
|
| 2005-03-24 08:41:00 |
Admission to Official List |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6726215384f908100eae507ac1afa2a2 |
Admission to Official List
|
| 2005-03-24 08:41:00 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e4ea8dada09c156040f3a9b1e077056c |
|
| 2005-03-24 08:41:00 |
ASX Listing Application & Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/510fded9d48874f6eadf9bfcdab53152 |
Stock Exchange Announcement - Other
|
| 2005-03-24 12:40:00 |
IPO Issue Heavily Oversubscribed |
0 |
https://app.sharelinktechnologies.com/announcement/asx/832eea655a1d8a5570488c2e6b607993 |
|
| 2005-03-30 18:14:00 |
Lists at a 37.5% Premium |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4cdc7bda3c93fbb6ee0c911976e2a0b |
|
| 2005-03-30 18:16:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f6c0d43383e3c9174275903573e7b06 |
Initial Director's Interest Notice
|
| 2005-03-30 18:16:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce26336a5abadf0ecc3da22386d1b782 |
Initial Director's Interest Notice
|
| 2005-03-30 18:16:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/759a19872e34f60ffcc81f1f80960b30 |
Initial Director's Interest Notice
|
| 2005-03-30 18:16:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/189e88018feba687d0209f4448846b5c |
Initial Director's Interest Notice
|
| 2005-03-30 18:16:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f0998ad83d14265b13a632cc3372df3 |
Initial Director's Interest Notice
|
| 2005-03-30 18:16:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e278428d6a7de2d67b03264d284023cd |
Initial Director's Interest Notice
|
| 2005-03-30 18:17:00 |
Becoming a substantial holder from BTC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7a22e4a907ebdf8d4054dc3bb6dc2a2 |
Becoming a substantial holder
|
| 2005-03-30 18:17:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1fa22f27a6cdbccf089aaad08cee529c |
Becoming a substantial holder
|
| 2005-04-06 09:35:00 |
New head of licensing & commercialisation program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da3a1bf5def367691cc0ef29ce1b4577 |
Company Administration - Other
|
| 2005-04-14 18:20:00 |
Change of Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/82d9b948ead824bf160974e7c96400a2 |
Details of Registered office address
|
| 2005-04-28 11:39:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e3c80dca7b40bf4a1e0ca3820bf98c89 |
Commitments Test Entity - Third Quarter Report
|
| 2005-05-02 08:32:00 |
US Patent Office Notice of Allowance |
0 |
https://app.sharelinktechnologies.com/announcement/asx/440312720712f243ebae4eba2a2eb3bc |
|
| 2005-05-12 16:47:00 |
Release of restricted securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87ea650397cba06fde13aa50182a7c82 |
|
| 2005-05-25 16:45:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4dec6adff79f22f9c8d23988c4cc29ce |
|
| 2005-06-02 09:01:00 |
Discovers new drug lead targeting stroke |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4d2c306c0a401bc460d240161065ede1 |
|
| 2005-06-14 08:31:00 |
Restricted Securities Release |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a6ed5335e780523eac9f8316cbcc8aaa |
|
| 2005-06-29 16:09:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3853d91d6b225c997a756fab2c910b58 |
|
| 2005-07-07 20:26:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4fe6e7c778f3260bbaa44845ea0cec57 |
Change of Director's Interest Notice
|
| 2005-07-07 20:26:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d29f83d6212e1fd40efc098ef42815e |
Change of Director's Interest Notice
|
| 2005-07-08 17:20:00 |
Change of Registered office address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8421502c0053c01561d389c0b47cc3ed |
Details of Registered office address
|
| 2005-07-13 09:18:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c786bb377a400f8375c5ef3518af6b0 |
|
| 2005-07-15 08:29:00 |
BIO 2005 Annual International Convention |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2650f7b1e33366a137dfa601830d0da |
|
| 2005-07-15 08:29:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4bf0d821c6a176be3100f1473ff71b41 |
|
| 2005-07-15 14:26:00 |
Re-release of Part of Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2b961db83bbd37b5a8bc71ba04b63bb9 |
|
| 2005-07-18 08:29:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e841cb2003b53f7f8d46d06f5824edf |
Change of Director's Interest Notice
|
| 2005-07-26 16:38:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9867a9c88db854b1f9bf81fc321031cb |
Commitments Test Entity - Fourth Quarter Report
|
| 2005-08-11 18:12:00 |
Grant of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/93f473bd582ea0c2846f95f9a075ba0a |
|
| 2005-08-15 08:30:00 |
Partnering Deal with Pharmaust |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d73e256c595dd57c4fef0437e0e27d9 |
|
| 2005-08-15 08:31:00 |
PharmAust and Phylogica Sign Partnering Deal |
0 |
https://app.sharelinktechnologies.com/announcement/asx/192b151705b48e841d570fcb8fd4ee75 |
|
| 2005-08-30 16:50:00 |
Collaboration with Fox Chase Cancer Center |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f9d46dc96c28789cc5e66aa69b495e4b |
|
| 2005-09-09 16:26:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/39e7a25ebc6face4707bef6b4d02b403 |
|
| 2005-09-29 09:14:00 |
European Patent Allowed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d94e67611abbe10c08844448daeef638 |
|
| 2005-09-30 08:28:00 |
Full Year Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e06bf9351dc4414e81cfb928e018f2e3 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2005-10-07 15:46:00 |
Annual Report 2005 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c82e0d171900dc78b8ca9ab12d95045 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2005-10-07 16:15:00 |
Shareholder Advice - Website Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/47a5aeaea77f238dee83e3072a3a2833 |
|
| 2005-10-18 09:34:00 |
Technology Licence from JHU & MGH |
1 |
https://app.sharelinktechnologies.com/announcement/asx/66da93bdfc1689ed7b7057122bb580f7 |
|
| 2005-10-19 08:30:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1af1d2cff4bf1e817befc42369d02f9 |
|
| 2005-10-19 18:29:00 |
Offer Information Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f1206cee5e137f5960974c2b930f4a5 |
|
| 2005-10-21 08:30:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0116e50bbbe7f40c3e4dda3c71fa43b1 |
Notice of Annual General Meeting
|
| 2005-10-24 13:11:00 |
Commercial Ready Grant $2.27m |
1 |
https://app.sharelinktechnologies.com/announcement/asx/06911f4b7842d0907773d86fc58ac9f1 |
|
| 2005-10-24 14:33:00 |
Grant Announcement Correction |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9035e53e6d6be4170c9c242d5c19112e |
|
| 2005-10-27 18:28:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/766923175bce815f94cf383eb887f859 |
Commitments Test Entity - First Quarter Report
|
| 2005-11-25 08:31:00 |
AGM Presentation by Chairman & CEO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e17c3144b12c92965f0aabceef374cc5 |
Chairman's Address to Shareholders
|
| 2005-11-25 15:44:00 |
Results of AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d34f4dbdc7325a3341801bed2c908648 |
|
| 2005-12-08 08:30:00 |
McComb Foundation Collaboration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa4c9d421197369f50398a21bf3156fc |
|
| 2005-12-22 14:15:00 |
Update Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f332164ec7046fcb0997705b25e971eb |
|
| 2006-01-03 08:31:00 |
Appendix 3B - unquoted options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8925be0e9af9c2bcbd325161e247b1a2 |
|
| 2006-01-03 08:31:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/026d124a2cbd56e7ebe89d16197ea8e3 |
Change of Director's Interest Notice
|
| 2006-01-03 08:31:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c291d85ce34cc8fe948489a2df36c35 |
Change of Director's Interest Notice
|
| 2006-01-03 08:31:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35e27fc137894be80c322eaf5068fba6 |
Change of Director's Interest Notice
|
| 2006-01-20 10:47:00 |
Signs international collaboration deal with Canadian Biotech |
1 |
https://app.sharelinktechnologies.com/announcement/asx/aa866fcf13c4e5d2fa43def27ce4e236 |
|
| 2006-01-30 08:31:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/13fb8277d91db05fd231139e607d69d2 |
Commitments Test Entity - Second Quarter Report
|
| 2006-01-31 08:31:00 |
Release of Restricted Securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9de5567c810c9f054ac2d85696d3de3d |
|
| 2006-02-01 08:31:00 |
Notice of Allowance European Patent |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb76790b07ec9f8edc8d153e3baccb8d |
|
| 2006-02-03 08:31:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aaae64e5c81ee2e6e4e80fb0068cc856 |
|
| 2006-02-06 08:30:00 |
Shareholder Update February 2006 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b1b8a509004843e3641ce8c62559036 |
|
| 2006-02-13 08:29:00 |
Nature Biotechnology backs Phylomer Technology |
0 |
https://app.sharelinktechnologies.com/announcement/asx/efa54c262b78bfce4f04e91342e3e999 |
|
| 2006-02-14 08:30:00 |
Appendix 3B - End of Restriction Period |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83bf162b8d85bee9b1c33f4cc485dbbf |
|
| 2006-02-21 14:15:00 |
Appendix 3B - Listing of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e630b5638256e8ca1c340780b79065e |
|
| 2006-03-03 08:30:00 |
Teams up with the Garvan Institute for novel diabetes drugs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4b29483749c0d38f408c359e8c75acef |
|
| 2006-03-08 08:30:00 |
Joins up with Baker Institute to help combat heart disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5d449bb1573f8218928e37d592cada1a |
Company Administration - Other
|
| 2006-03-10 08:30:00 |
Biosquare Conference Presentation Geneva |
0 |
https://app.sharelinktechnologies.com/announcement/asx/837dfde06e997d1b36eb04f2049a537c |
|
| 2006-03-15 15:01:00 |
Half Year Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5145e1261a70021c4380d217dd87a5a4 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2006-03-15 15:05:00 |
Half Yearly Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c831dcc6a0d6a8622a7aa8cee2c02831 |
|
| 2006-03-16 08:28:00 |
Opsona Therapeutics Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5bb65d1ce5348e6f12995af46e5cade2 |
|
| 2006-04-27 09:47:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7b003ab0672d4b444d62de94ae368b3 |
Commitments Test Entity - Third Quarter Report
|
| 2006-05-02 10:07:00 |
Audio Broadcast Company Briefing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06c1950d00f4916250da9e5fe2d3bb32 |
|
| 2006-06-01 08:30:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d37e9a3980d2579eb61feac67e80ac77 |
|
| 2006-06-08 08:36:00 |
Signs Agreement with Johnson & Johnson |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1dad8605d77a1582314e7907bd973c28 |
|
| 2006-06-27 08:31:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/057562d5bc46829f9f63062bc352e6b5 |
|
| 2006-07-10 08:31:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f95fd06007ce5ae1a0029909e3470f7 |
|
| 2006-07-17 15:42:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1749b154e85816e2bdd52af3f5435dd1 |
|
| 2006-07-31 08:31:00 |
Commitments Test Entity - Fourth Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/32b5f320b8b3a3453e16d9565a162b64 |
Commitments Test Entity - Fourth Quarter Report
|
| 2006-07-31 08:31:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2615d458fd2e7d264d2861c03d133b8 |
Change of Director's Interest Notice
|
| 2006-07-31 08:31:00 |
Stroke drugs pass major test |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9d6990bd407379487b3853af44a51b4c |
|
| 2006-08-23 08:29:00 |
Phylogica drugs significantly accelerate burn healing |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e370fd74de94ec396e538ccd436edd7 |
|
| 2006-08-28 09:28:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/14e4a34575c4dd1fba272be96c0f8bed |
|
| 2006-08-29 18:09:00 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bc4294a3499e09605f6deaaaf7324aaa |
Suspension from Official Quotation
|
| 2006-08-31 09:41:00 |
Announcement to end suspension |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a342d81bebdbd06b6367079ade83cddb |
|
| 2006-08-31 09:41:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/971e1dab90c3a1acfaa3aff591ca1698 |
|
| 2006-08-31 09:49:00 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc349dc48ed625eca72d1a36727137f4 |
Reinstatement to Official Quotation
|
| 2006-09-04 08:29:00 |
European Patent Granted |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de6adc0474a8e46f7aaa82c24a300c7b |
|
| 2006-09-13 08:30:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8416d053e0a6745400a0da28b8f9c617 |
|
| 2006-09-21 13:00:00 |
Placement & Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38f0cee6f7887298eb78e05f06b3df7e |
|
| 2006-09-22 08:28:00 |
Drug source libraries increase 400% |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2161018b084d56b12da338487bcc8c7d |
|
| 2006-09-27 11:16:00 |
To present at prestigious Sachs Investor Conference inEurope |
0 |
https://app.sharelinktechnologies.com/announcement/asx/823842b1c882ceaa522b605c5ff9a8de |
|
| 2006-09-28 14:11:00 |
Full Year Accounts 2006 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/480ecb19828794055517847c2b6f2386 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2006-10-02 08:28:00 |
Share Purchase Plan Mailed - Part 1 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/690b024d6218c9c2503bcd4fcbd6203f |
|
| 2006-10-02 08:30:00 |
Share Purchase Plan Mailed - Part 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7eef3c3055fc78488b9961f2edaa4efb |
|
| 2006-10-05 08:25:00 |
Rheumatoid Arthritis Milestone |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8bee78dd5c2ac42426590da60b16952e |
|
| 2006-10-20 11:20:00 |
Capital Raising Concluded at $3.75m |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e96562031a2dc0d7157a81ca332af2ef |
|
| 2006-10-24 11:06:00 |
Phylogica Delivers on International Drug Co-Development Deal |
1 |
https://app.sharelinktechnologies.com/announcement/asx/966ce7991d35a4e0d7cecd7ad97776f7 |
|
| 2006-10-27 12:10:00 |
Phylogica featured on ABC Catalyst Program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ceaa03e4109e9cdcfb978f68b590091 |
|
| 2006-10-30 08:28:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/198e24a5b53de25860b83760eeedc60f |
Change of Director's Interest Notice
|
| 2006-10-30 08:28:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7cc17fb653658835d0f868e4442ffd75 |
Change of Director's Interest Notice
|
| 2006-10-30 08:28:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0edaf090b30d6b7bad0c46ad2e805ec4 |
Change of Director's Interest Notice
|
| 2006-10-30 08:28:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e30f037014576c13c263f960571665fe |
Change of Director's Interest Notice
|
| 2006-10-30 14:52:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e537826964c82ac6f637a052b7792518 |
Notice of Annual General Meeting
|
| 2006-10-30 15:04:00 |
Commitments Test Entity - First Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/08805d5fd55a457b8b19c3b5796c1abc |
Commitments Test Entity - First Quarter Report
|
| 2006-10-30 15:21:00 |
Annual Report 2006 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9d0fcc507cc12a92d87c6582fff737c |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2006-11-10 10:29:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ecaa7d38c6524fee33a795e17deda3a |
|
| 2006-11-10 10:29:00 |
Notice under Section 708A(5) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df45c0980d0a257355fa49f83ac6d02f |
|
| 2006-11-24 11:52:00 |
Director Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1f87406c9edae20a8bb07118f81a26b |
Director Appointment/Resignation
|
| 2006-11-29 10:56:00 |
Delivers on Key Milestones |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d3da1ba8dd2358ba233a174618e490fe |
|
| 2006-11-29 11:17:00 |
AGM Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b76247013dc79c61d50f244d504574ad |
Chairman's Address - Other
|
| 2006-11-29 13:18:00 |
Annual General Meeting Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17384bcdfa7f4616415c6a538da72c51 |
|
| 2006-12-04 12:48:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3a91d50f99c1799b45c3b85831e72b8 |
|
| 2006-12-05 08:30:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d603b2d8339a2118e0d9a6d28eb521a |
Final Director's Interest Notice
|
| 2006-12-07 10:30:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0375775f425e3712f79f552bf23f18e9 |
Change of Director's Interest Notice
|
| 2006-12-07 10:51:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/777368fb03a749463ec6640914337cb3 |
Change of Director's Interest Notice
|
| 2006-12-11 10:39:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17693f8ca1ccf8b163390863551f1f05 |
Change of Director's Interest Notice
|
| 2006-12-13 11:14:00 |
New Application for Phylogica Stroke Drugs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f84af3c4255d4060b619f218b318d457 |
|
| 2006-12-15 08:30:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17c83d14714c8a006d57b000c5033a82 |
Change of Director's Interest Notice
|
| 2006-12-15 15:01:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f185c7850b6e6883073249368cba366a |
Change of Director's Interest Notice
|
| 2006-12-20 10:13:00 |
Invited to present at International Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/567d18c7dc5df67ad3ce37c8cc02ac94 |
|
| 2007-01-29 12:58:00 |
Appoints Head of Drug Development |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc11c870c08356bd31a38c3b9fe6f114 |
Company Administration - Other
|
| 2007-01-30 14:23:00 |
Commitments Test Entity - Second Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c7a40e9b22dc225f9a61aa0ece6c8ec5 |
Commitments Test Entity - Second Quarter Report
|
| 2007-01-30 16:56:00 |
Change in substantial holding from BTC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63c9b73112e2e86d1b4fd490235154b3 |
Change in substantial holding
|
| 2007-02-07 14:12:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5c2ff5e4dd6ff092129d92d2e0c0c6f |
Change in substantial holding
|
| 2007-02-21 10:37:00 |
Former Pfizer VP Joins Phylogica Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a5cde459ed170a8d625513df8feda8b |
Company Administration - Other
|
| 2007-02-21 12:17:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b45ce5d66c66c2199458dd29debac996 |
|
| 2007-02-21 12:19:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7e2ccb5a2842e31cfd136eea01201ce |
Initial Director's Interest Notice
|
| 2007-02-22 18:56:00 |
Half Yearly Report & Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b355d6f68f3d5f8d7efc05b840a84b48 |
|
| 2007-03-07 10:56:00 |
Awarded Grant for Head Trauma Drug |
1 |
https://app.sharelinktechnologies.com/announcement/asx/677df88e0a500709360798974a44bc2d |
|
| 2007-03-15 17:07:00 |
Release of restricted securities from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/270b88018efb22420502e58d2012884e |
|
| 2007-03-16 18:55:00 |
Appointment of Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b387189a903b8f8f05f5af32d41177a |
Company Secretary Appointment/Resignation
|
| 2007-03-30 10:48:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cf24786447eafe0f24730d7cc444a572 |
|
| 2007-04-20 12:38:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fac0f702984e45f080975af47e5d0b65 |
Change of Director's Interest Notice
|
| 2007-04-23 15:42:00 |
Commitments Test Entity - Third Quarter Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f9fa68225cd93a2fcaa69cf0004f18e0 |
Commitments Test Entity - Third Quarter Report
|
| 2007-04-27 12:37:00 |
Independent Research Report by WH Ireland |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc1e95145c5ccfd85701ae0569d593cc |
|
| 2007-05-07 10:53:00 |
Phylogica-Opsona Deal progresses to commercialisation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2b7c83ba6f31ffd01d1f943ca8cd604 |
|
| 2007-05-10 10:57:00 |
Intersuisse Research Report on Phylogica |
0 |
https://app.sharelinktechnologies.com/announcement/asx/500cd1a2823b76436bd2084123bd1bc7 |
|
| 2007-05-15 11:21:00 |
Announces Generation of Rheumatoid Arthritis Hits |
1 |
https://app.sharelinktechnologies.com/announcement/asx/166b94cea1afca9fbd1c50ac590db99e |
|
| 2007-05-22 18:57:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2378bb599e105b5c704eaf492b84dd57 |
|
| 2007-06-06 10:57:00 |
US Patent Allowance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2ff82995694a1a9bde8f7384c36a6655 |
|
| 2007-06-12 08:27:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/853c3ed37c6677f63259aeca221c7207 |
|
| 2007-06-26 17:17:00 |
Option Underwriting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d759fbc34c6419acc5805c67b4d144a |
|
| 2007-07-05 11:33:00 |
Expands Pipeline to Acute Lung Distress |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa61c5a1dd77ad4e89a22d5e3de6e58e |
|
| 2007-07-11 12:05:00 |
Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a660c4676c97d00aa631ef5817850b68 |
|
| 2007-07-16 10:50:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a2d061420fc97c1b6f7ce4d277e231c4 |
|
| 2007-07-30 11:04:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0fad3749a6a3749b3ff4e1f4dfd0f534 |
Commitments Test Entity - Fourth Quarter Report
|
| 2007-08-01 12:03:00 |
Letter to Shareholders (b) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a574dfcc95b437964a5b18d0cd821e96 |
Letter to Shareholders - Other
|
| 2007-08-01 12:03:00 |
Letter to Shareholders (a) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48e7cd31f3142ad32f5ff916d437854e |
Letter to Shareholders - Other
|
| 2007-08-17 15:08:00 |
Company Secretary Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5eb05d1bb1e2caa6c13bd96ad225122 |
Company Secretary Appointment/Resignation
|
| 2007-08-23 18:00:00 |
Appendix 3B Options Exercised |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00e962acf432911e31cecfc27fcacf0e |
|
| 2007-08-24 11:57:00 |
Phylogica Enters Anti-Microbial Field |
1 |
https://app.sharelinktechnologies.com/announcement/asx/482bcf7d320cfb021e77d652865c062f |
|
| 2007-08-30 08:28:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2187e1cca246a9ea19668987b76d1c4b |
|
| 2007-09-03 14:02:00 |
Appendix 3B Option exercise |
0 |
https://app.sharelinktechnologies.com/announcement/asx/afcad9db8c9126dfceaf119110c177b4 |
|
| 2007-09-05 17:21:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/10d254a025a506a8dd83e2a0d18f6d0a |
Becoming a substantial holder
|
| 2007-09-10 12:17:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/095a12bd11ca8bf2c4183070aa0ee92b |
Change of Director's Interest Notice
|
| 2007-09-10 12:22:00 |
Option Exercise Completed |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6340b0d3d83032b2c890d379b64c0c71 |
|
| 2007-09-17 15:24:00 |
Appendix 3B underwritten unexercised options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64871e390070a0c3781a657caf4bf5f3 |
|
| 2007-09-25 08:27:00 |
Change in substantial holding from BTC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4108cfb6a3e24078eb1243d8fe66247f |
Change in substantial holding
|
| 2007-09-25 08:27:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/927d82ca6185d877e5d1102f631acf74 |
Change in substantial holding
|
| 2007-09-27 12:07:00 |
Allergy Research Collaboration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00f79842d53e4a0de66e02a9c1480194 |
|
| 2007-09-28 08:20:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a3eae036a3a0622fb47973caaac39b61 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2007-10-10 10:18:00 |
Rhematoid Arthritis compounds validated |
1 |
https://app.sharelinktechnologies.com/announcement/asx/db512ef0e124a6eebc93f16bfb6caad8 |
|
| 2007-10-23 12:27:00 |
Burns Drug for Human Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/50d06b1dc80741d122bade5d0f39b7fa |
|
| 2007-10-26 09:34:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85166856689a3b773cf3e9b242448772 |
Notice of Annual General Meeting
|
| 2007-10-26 09:37:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa789f207650559335287737310bec5f |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2007-10-26 13:10:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d956df921baaa3c9d3a5a0b8300af4c1 |
Letter to Shareholders - Other
|
| 2007-10-30 09:27:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b64539178d517af5a9e471c3726d1e58 |
Commitments Test Entity - First Quarter Report
|
| 2007-11-06 14:15:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4901b8c0ac06759efa89e0efa4032441 |
Change of Director's Interest Notice
|
| 2007-11-07 17:33:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0cec57406466616ddde95016a8ddf494 |
Change of Director's Interest Notice
|
| 2007-11-19 12:56:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17b382e5e63eb96ef37748d7fa52cd18 |
Change of Director's Interest Notice
|
| 2007-11-22 16:04:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b8fe44dc33d903eb9132d9afb15e803 |
|
| 2007-11-28 08:38:00 |
AGM presentation to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4196b7996542972a79d2da89a1655ab5 |
Chairman's Address to Shareholders
|
| 2007-11-28 13:00:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2286430922c323e2878e2a65eaec5cb2 |
|
| 2007-12-04 19:19:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76c8d62fbbd1b9bb2a7cf7633a5451b5 |
Change in substantial holding
|
| 2007-12-06 09:59:00 |
Strategic Direction Announcement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cf41c0c680107eda747339c6592cb8a7 |
Company Administration - Other
|
| 2007-12-10 10:45:00 |
Director Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b84dda08cee5ff29e5d16dbed69a6fe |
Director Appointment/Resignation
|
| 2008-01-03 15:05:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f301bff75c8a20629474ef752b877bf |
Initial Director's Interest Notice
|
| 2008-01-21 11:44:00 |
Co-Marketing Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/51b5aca459dd173b22779bd9f8bcd2f5 |
|
| 2008-01-31 12:18:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9924be7c4e4aa0ddb1fd0b128c6de98 |
Commitments Test Entity - Second Quarter Report
|
| 2008-02-19 10:55:00 |
Extra Funding for Phylogica Programme |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53364c99bc752d92a3369678e323866a |
|
| 2008-02-25 10:03:00 |
Phylogica Strategic Direction Announcement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ebf53aa7339a4de3f898da369892861 |
Director Appointment/Resignation
|
| 2008-02-27 10:38:00 |
Director Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a37c00220a8387e30e9df3ed6a6a651d |
Director Appointment/Resignation
|
| 2008-02-28 12:49:00 |
Half Year Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/384863419fb9cafdfde215c2ee5bbd01 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2008-02-28 12:53:00 |
Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98fe92611805ad110e14ee1a63b972d8 |
|
| 2008-03-05 16:42:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/977262f6410d26f1e335fdaba5344f57 |
Notice of Meeting - Other
|
| 2008-03-06 18:50:00 |
Phylogica Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/660dff8c022c8b778443899d0f82722a |
Chairman's Address to Shareholders
|
| 2008-03-10 15:41:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/57bed8c66ee289d17229e9e02d6292ca |
Change of Director's Interest Notice
|
| 2008-03-12 14:06:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/181dc1a4ccda3385d642be72ace34575 |
Change of Director's Interest Notice
|
| 2008-03-17 12:32:00 |
Dynamic Licence Annoucement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8cec8ff84acde4b19b10d8e738a3e4b |
|
| 2008-04-22 16:51:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6e85579d64269f9534e57d0f012d672 |
Change of Director's Interest Notice
|
| 2008-04-30 12:27:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/235ede6c4e8ff183d1862efa5bb17a43 |
Commitments Test Entity - Third Quarter Report
|
| 2008-05-08 15:42:00 |
Share Announcement - Clears Opes Prime Overhang |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee422166eaeffdc4160716c01d63738b |
Security holder details - Other
|
| 2008-06-12 14:43:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/467da6219f6c1ca8efbc2ebbe22a7a4f |
|
| 2008-07-30 15:52:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c820c0f761851acb6091ab31677e81c6 |
Commitments Test Entity - Fourth Quarter Report
|
| 2008-08-18 15:07:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8fe2266a481a46190899af10661d50c |
Change of Director's Interest Notice
|
| 2008-08-27 09:53:00 |
Phylogica Beats Technical Hurdles |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fc7d81d9b32ed361ce8bf35fd35d4b7 |
|
| 2008-08-29 09:09:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bdd8c421044f97f884b79ac13665e8e7 |
|
| 2008-09-04 09:59:00 |
Phylogica Signs Cancer Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/483486a458c71f17edc43adc8830cb52 |
|
| 2008-09-30 18:02:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b2be75e04194532e915b18ae204b5604 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2008-10-24 14:55:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/297ad2ff4e25b89cee0f299f914ed3c9 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2008-10-24 14:58:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/79651ac083049acd3b3fd3367d999f47 |
Commitments Test Entity - First Quarter Report
|
| 2008-10-24 14:58:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6496489773c8194aca9023270014f01e |
Notice of Annual General Meeting
|
| 2008-11-24 12:33:00 |
Phylogica aquires all shares in associate |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9f0c12870adb2bcf253e6c757216b95e |
|
| 2008-11-24 12:33:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cfba24e0c9f9397a58c80a1600cf909 |
|
| 2008-11-26 10:27:00 |
Chairman`s Address to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac98a0cd0cd71af353943b8d9722f821 |
Chairman's Address to Shareholders
|
| 2008-11-26 12:39:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30642f0c9a9a3f367256eb824c17dc2c |
|
| 2008-12-04 13:47:00 |
Holding Statement`s Dispatched |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11b5bd1474ca3a08dfb1f9627a869375 |
|
| 2008-12-04 13:51:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a026db85dcf4765606f1d2666856c20 |
|
| 2008-12-05 13:33:00 |
Director Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/143483c5d43d9e44c145a403504573f6 |
Director Appointment/Resignation
|
| 2008-12-05 17:14:00 |
Change in substantial holding from BTC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51c65af0679fb87906554d1620448b84 |
Change in substantial holding
|
| 2008-12-08 12:44:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11669f0830220bbe951a165eebdb648a |
Change in substantial holding
|
| 2008-12-09 16:20:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec2b2a4e89c9e29a870dc14388d8c7a1 |
Change in substantial holding
|
| 2008-12-09 16:22:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a47d48d4802de4e2a80dc685214dd024 |
Final Director's Interest Notice
|
| 2008-12-18 11:44:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2fe22b0291b8656b87fb868733b85062 |
Notice of General Meeting
|
| 2008-12-22 08:27:00 |
Company Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de8d5d81efe3ed872ce5cd29a6eadb3d |
Director Appointment/Resignation
|
| 2008-12-22 18:01:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfca02ed546af83d8d52b42f8b90aaae |
|
| 2008-12-22 18:04:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abe118c8b7bd29537d502364d9bc686f |
Change of Director's Interest Notice
|
| 2008-12-22 18:12:00 |
Change of Director`s Interest Notice Amended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/359287ff7da8806379f1fe424e671de0 |
Change of Director's Interest Notice
|
| 2009-01-16 13:21:00 |
International Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7880084c0675c1da6a56fefdcd16632 |
|
| 2009-01-19 12:33:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/129b7bb8141b6fc246b3549b54b11d98 |
|
| 2009-01-30 11:59:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a323971d1a5f555cb3862d2e71fd9bc0 |
Commitments Test Entity - Second Quarter Report
|
| 2009-02-11 14:10:00 |
Details of Company Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eee3ffb8f7df80f014ea306221e55e56 |
Details of Registered office address
|
| 2009-02-26 08:28:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6c71b909c11b83d645acab691d92e6b8 |
Notice of General Meeting
|
| 2009-02-26 18:49:00 |
Capital Raising Programme |
1 |
https://app.sharelinktechnologies.com/announcement/asx/221d4b0288dd564f12171e05b4c0fbae |
Security holder details - Other
|
| 2009-02-27 15:21:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea91d79b3f0b74d32a02f3f58e8da026 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2009-03-04 18:29:00 |
Collaboration with the MRC Hutchison Institute a success |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c7702a03dc6216f271b2750b228f058 |
|
| 2009-03-27 11:58:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/79744199c46674891bed6d160c686f79 |
|
| 2009-04-14 12:10:00 |
Drug Delivery Collaboration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4396abb85865ad08ef590c760a1ed1e5 |
|
| 2009-04-22 12:43:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abaddb605437c0466297d839b63e9da8 |
|
| 2009-04-22 12:45:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e3e766245a06c8091f9936cd467bfbe |
|
| 2009-04-22 12:46:00 |
Sucessful Capital Raising |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a700ae324de498f99b4029899c4e6ad |
|
| 2009-04-29 16:51:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/960bf21a867d7a809aed0b6ce2613358 |
Change in substantial holding
|
| 2009-04-30 12:54:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc88c6d42cd5046df7900e60b599883a |
Change in substantial holding
|
| 2009-04-30 12:57:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6859edadef11debe2e50ac0d81d1340 |
Commitments Test Entity - Third Quarter Report
|
| 2009-05-05 12:36:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a25595edd55f8140cff6083abe60188 |
|
| 2009-05-05 12:39:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8a7be8a4110baa975189e20e921e4b7b |
|
| 2009-05-05 12:47:00 |
Pro-forma Cash Position 31 March 2009 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c6e2002b0709e64dd3b192b698569438 |
|
| 2009-05-06 16:47:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/015f84aff7fbe95896b0a9e692448524 |
Change of Director's Interest Notice
|
| 2009-05-06 16:48:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea3f8b640a677970888b2ab6bb9305ba |
Change of Director's Interest Notice
|
| 2009-05-06 16:50:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f65597364b039168f5898310b62035e |
Change of Director's Interest Notice
|
| 2009-05-06 17:10:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40e1c508b212e23c96c83958c6447c5e |
Change in substantial holding
|
| 2009-05-06 19:00:00 |
Change in substantial holding from BTC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9265f2a3b6bd2f9b5aadff4d53713a8 |
Change in substantial holding
|
| 2009-05-07 18:25:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfc5bf4d5a126e7e33827b25140a62e7 |
Change in substantial holding
|
| 2009-05-08 17:13:00 |
Response to ASX Appendices 3Y Query |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1aaa806189fe0f4451c13273926e64e8 |
|
| 2009-05-11 16:13:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd04565cdf38e9de3d133fc5f34d1126 |
Change in substantial holding
|
| 2009-05-25 09:56:00 |
Director Appointment/Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/228765263ff9ce565bf40afa4aaf2484 |
Director Appointment/Resignation
|
| 2009-05-25 12:51:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f146cfa0d4309bd26bf61b9399aec6e |
Final Director's Interest Notice
|
| 2009-05-25 15:54:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30e51ec70a8819c52fae6bcfaf96220a |
Initial Director's Interest Notice
|
| 2009-06-03 17:54:00 |
Appoint Company Secretary and Change to Registered Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/569aba0e921338daa830f51f6845ed60 |
Details of Registered office address
Company Secretary Appointment/Resignation
|
| 2009-06-22 13:32:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad879b902750e1909ab0f6d476a500c8 |
|
| 2009-07-29 16:59:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/24bdf76b2f6c5cc98fbbe30f860de31e |
Commitments Test Entity - Fourth Quarter Report
|
| 2009-08-03 13:19:00 |
New Patent allowed for Phylogica`s anti-inflammatory peptide |
1 |
https://app.sharelinktechnologies.com/announcement/asx/699a149b3c6efc5c953650d231ea0f6d |
|
| 2009-08-21 11:30:00 |
International Investor Relations Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/495a7bbb08a8baef43f42f76eb0290c0 |
Company Administration - Other
|
| 2009-08-26 12:46:00 |
Advanced Negotiations |
1 |
https://app.sharelinktechnologies.com/announcement/asx/080aad3230482b0aaa25099e11255c63 |
|
| 2009-08-28 16:15:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/37aba0d07c21edfd33f62f60441acc3f |
Notice of General Meeting
|
| 2009-08-31 17:01:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0bd0ae8d323cb7cd056f2a11ab2ab28d |
|
| 2009-09-10 15:23:00 |
Response to ASX Price and Volume Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b2601e87d3901124e947b5b11f0c95d |
|
| 2009-09-24 17:19:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/24b41d48219e1a3aa6842119b1375cf9 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2009-09-30 12:29:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f216d2c9c6a6ff97747c9978abbdc871 |
|
| 2009-10-02 13:19:00 |
Phylogica Presents at Roche Peptide Symposium |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8aed3da553ee76b0d5b5bdcba8102a20 |
|
| 2009-10-22 14:42:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c50d93707456dcaba87651817e4af531 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2009-10-22 14:43:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6794c2836e961000d1e5c39ccebde8a5 |
Notice of Annual General Meeting
|
| 2009-10-30 16:06:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/386f143efcfde27a1dc086a6ca9ba70e |
Commitments Test Entity - First Quarter Report
|
| 2009-11-05 17:56:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4e95c8a5ff74d95b2ef48c772d722e7 |
|
| 2009-11-05 17:56:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20f1e7270890ea8a90cd7bcdf8fb64d8 |
Change of Director's Interest Notice
|
| 2009-11-25 16:13:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6975c3c945721c636b198d47b88d2e94 |
|
| 2009-11-25 16:18:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9dbe414bf8d47be8111040cc56fd6e34 |
Chairman's Address to Shareholders
|
| 2009-12-02 13:53:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e298915d64e2e80b818e43decde361e0 |
|
| 2009-12-02 14:01:00 |
Trading Halt Request |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e78c35f6a027b5832f8bdb18003a096 |
|
| 2009-12-03 17:51:00 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5357fce1fb488bf55dc493b95bb776c0 |
Suspension from Official Quotation
|
| 2009-12-08 16:38:00 |
Completion of fund raising and partnership negotiation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f090cfb66a8b312d7f2d26532909805e |
|
| 2009-12-08 16:39:00 |
Reinstatement to official quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/589ce8ae883e610e6e268fe737479057 |
Reinstatement to Official Quotation
|
| 2009-12-17 09:54:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7e5c1dbbd37ffca7c3719ad68768dfa1 |
|
| 2009-12-18 16:54:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b410c079dea2b809a4ac9b84b327b83f |
|
| 2009-12-18 16:55:00 |
Section 708A(5) notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b89c741caa7c15dbe1136bf639dd83b7 |
|
| 2009-12-18 17:10:00 |
Phylogica Signs Agreement with Roche |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15379853d2d0e009aba7e513fd87918d |
|
| 2009-12-21 10:02:00 |
Roche Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff2a06d227bf46428c876f2e48073f2f |
|
| 2009-12-22 13:31:00 |
RB Milestone Group - Research Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d139c5f3d3f5412c7553b8c9a259749 |
|
| 2010-01-15 18:01:00 |
Phylogica`s 2010 Technical and Investor Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b720ae0a27bcfe56cacc7598d1e5b72a |
|
| 2010-01-18 12:58:00 |
Agreement with Major UK company to Build New Drugs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8a4b7b80b04c3564a073499fec924ee |
|
| 2010-01-19 18:41:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07afc1f3f68e327494db25ce3f3f11fc |
Change of Director's Interest Notice
|
| 2010-01-22 15:12:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83e44f372872bc9350e19e59f61d0d55 |
Change of Director's Interest Notice
|
| 2010-01-22 15:15:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72571051a3b708a31e91ab424bff95ca |
Change in substantial holding
|
| 2010-01-29 13:24:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/453ec7ec513ebc994038597f8aead04a |
Commitments Test Entity - Second Quarter Report
|
| 2010-02-19 13:19:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f8b764441eb790521cd6a1f766d87223 |
Change of Director's Interest Notice
|
| 2010-02-24 18:00:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2937c82ff71cd047bba571c0e36360fb |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2010-02-25 11:59:00 |
Phylogica`s Shareholder Update Pharmaceutical Deal Pipeline |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f2782a07e607aa4268aaa27f2939512 |
|
| 2010-03-02 13:37:00 |
New Patent Allowance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2d6677f2459b33619616aa85ce7ef11 |
|
| 2010-03-17 12:33:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b964f13c3844f0fad0ba8958babaf26d |
Change of Director's Interest Notice
|
| 2010-03-22 11:44:00 |
Road Show Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1b2a39205414ac6c30bf38fe51caadf |
|
| 2010-04-08 10:49:00 |
Finance News Network Interview with CEO and Chairman |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d37ea343f0366b48af00d5833b23bdf |
|
| 2010-04-22 10:20:00 |
Mr Nick Woolf Appointed Non Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4963c55be2d9f6b4e1bde903d5d482c8 |
Director Appointment/Resignation
|
| 2010-04-22 10:22:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ddedd5a428325b82bb266c29b679866 |
Initial Director's Interest Notice
|
| 2010-04-30 13:59:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ea5d092f8b32729c63dbd14645e8f2d |
Commitments Test Entity - Third Quarter Report
|
| 2010-05-18 11:06:00 |
Frankfurt Stock Exchange Listing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abf2038b89714542c535787eff58a62f |
|
| 2010-05-19 11:18:00 |
Rodman and Renshaw Global Healthcare Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0718536caf4fc6a4e62607e11b0af366 |
|
| 2010-07-13 17:05:00 |
Board Change |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bdd71edd37005234c2e243f70dbfa6cd |
Director Appointment/Resignation
|
| 2010-07-13 17:09:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e37b44b51db8cd735b8a6a3e9e7c775c |
Final Director's Interest Notice
|
| 2010-07-30 16:13:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a406a6ce64a9b1c94898105b04d10381 |
Commitments Test Entity - Fourth Quarter Report
|
| 2010-08-03 15:18:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d92bd3218ded10999a227c34536be27d |
|
| 2010-08-05 09:17:00 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4441d06f9bd6dbb4792a88362893a351 |
Suspension from Official Quotation
|
| 2010-08-09 15:52:00 |
Response to ASX Query - Appendix 4C |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e9632128b704150e6cb69a06f93f8cff |
|
| 2010-08-16 11:53:00 |
Agreement update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b468e9faca1802c9c31a5e58127d5b8 |
|
| 2010-08-18 09:33:00 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8d177023dfe30e21ad5fc7d572d9365d |
Reinstatement to Official Quotation
|
| 2010-08-18 09:34:00 |
Phylogica Signs Agreement with MedImmune / AstraZeneca |
1 |
https://app.sharelinktechnologies.com/announcement/asx/05a6caaa86d03d7ad24708cde5a6aa04 |
|
| 2010-08-19 11:27:00 |
Finance News Network Interview with Director Nick Woolf |
0 |
https://app.sharelinktechnologies.com/announcement/asx/15e54d26a9920907a06bb4ef10ef5c76 |
|
| 2010-08-19 12:24:00 |
Bioshares CEO Interview P Watt |
0 |
https://app.sharelinktechnologies.com/announcement/asx/52628e9cdda721c75cc33be3874b693d |
|
| 2010-08-23 11:23:00 |
US analyst values Phylogica at significant premium to market |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9bd8332364bd66f03d896e66de2376b |
|
| 2010-08-23 17:42:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/93ff5baee516af2367590858e1fc0eda |
|
| 2010-08-26 09:22:00 |
Fully Underwritten Renouncable Rights Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2c45a337360673d86ebca83db543580 |
|
| 2010-08-26 18:28:00 |
Rights Issue prelim Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8fd8af26a369cb256c8eb9858e859e04 |
|
| 2010-08-30 18:56:00 |
Renounceable Issue Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38f39a169427a6bb56bf12ae1149e13c |
|
| 2010-08-30 18:57:00 |
Renounceable Issue Shareholder Letter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/74e14a780c02927f2f7908f4cf38f9ae |
|
| 2010-08-30 18:57:00 |
Renounceable Issue Optionholder Letter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9c6066f012482ceb1e203fee2c51bdf |
|
| 2010-08-31 14:47:00 |
Amended Appendix 3B Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/55cc3e72dbddf39aa38e9f0ef4318fe0 |
|
| 2010-08-31 17:28:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b49cc33f3fa793f611b45135f04d8bdd |
|
| 2010-09-03 12:04:00 |
Investor Presentation Post MedImmune |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d89ee6ad26a3ed56c773abcbbb68f9c |
|
| 2010-09-08 16:25:00 |
Further Statement Licensing Agreement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/09a96f7315adeb87ae233e0d30ce9488 |
|
| 2010-09-08 19:31:00 |
Replacement Prospectus Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef59dc4757f6d3e8791a8ef22106d44a |
|
| 2010-09-10 14:46:00 |
Despatch of Right Issue Documents |
0 |
https://app.sharelinktechnologies.com/announcement/asx/62f4b714149b9f557efb9e0972eee1e4 |
|
| 2010-09-22 12:06:00 |
Interview with Mr Nick Woolf Non Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f15940bba2238453524710c06e08812 |
|
| 2010-09-23 08:32:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/835cf503f41bf0edbe7905e6e35fa417 |
Change of Director's Interest Notice
|
| 2010-09-28 16:40:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8233c539d0b59d93021445427fb281b |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2010-09-29 18:15:00 |
Solid Uptake in Rights Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8481e02a0cc03e92753f95c1f70f2f71 |
|
| 2010-10-04 15:09:00 |
Appendix 3B rights issue Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb836e034e02a0419e8673d591de2bee |
|
| 2010-10-05 17:49:00 |
Change of Director`s Interest Notice x 3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/614ad81d9121d6d1dc82fe33b656a6cf |
Change of Director's Interest Notice
|
| 2010-10-07 12:55:00 |
Australian Life Science Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa9740339d001e309889e606d0ffd5ff |
|
| 2010-10-08 13:21:00 |
Appendix 3B rights issue Underwriting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ef5dd6f5dd8bd6e7135150b4dbd96f8 |
|
| 2010-10-13 18:53:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1dacf2138db40845c2b79921f4d6516a |
Change in substantial holding
|
| 2010-10-14 12:17:00 |
Executive role appointment - N Woolf |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85a0c41e0f164121ae0c468adbf1ff32 |
Company Administration - Other
|
| 2010-10-15 18:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b34e2dee27953d6ac453fa9bc79cb9c |
Change in substantial holding
|
| 2010-10-21 10:51:00 |
PHYLOGICA AND ROCHE COMPLETE FIRST STAGE OF PARTNERSHIP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a39c9d9e5216e01d755f7c167a8fe8f3 |
|
| 2010-10-21 16:09:00 |
Roche Ausbiotech 2010 congress - Phylogica Partnership |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b5ff4f9a697b7ceedc005fb522bbe711 |
|
| 2010-10-28 13:54:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76c421fae1758b6cce6d15255846b6cf |
Notice of Annual General Meeting
|
| 2010-10-28 13:55:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4329ac5a30be859e223258b5044537a |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2010-10-29 15:24:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1e48726a1ce1bcd6bb4ac11c28099c68 |
Commitments Test Entity - First Quarter Report
|
| 2010-11-02 13:01:00 |
MedImmune drug discovery activities commence |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b71d2b812bcc944b6c6e953f90ed4dbb |
|
| 2010-11-30 14:02:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/507c603589f5137cb4f2ab0e01311cb3 |
|
| 2010-11-30 14:10:00 |
AGM presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98102c071609b41aafbe635deff8e60c |
Chairman's Address to Shareholders
|
| 2010-12-06 16:44:00 |
Final Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c3c3212c9e4ca21dcb21594bd3352d55 |
Final Director's Interest Notice
|
| 2010-12-07 10:00:00 |
Chairman`s Update 2010 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e53af7e3d1f7c92a3a525fbb9a15345 |
|
| 2010-12-16 10:06:00 |
Interview Nick Woolf CFO and VP Corp Development |
1 |
https://app.sharelinktechnologies.com/announcement/asx/495d77a5635d84d8d9c58025a48c4d6f |
|
| 2010-12-17 17:45:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb6619ba21d3788d72bdc24d45a202c9 |
Change of Director's Interest Notice
|
| 2010-12-17 17:49:00 |
Appendix 3B AGM issues |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2de29ba5546a3b19c76485c61aafc0a4 |
|
| 2010-12-20 08:45:00 |
Phylogica Signs Collaboration and Licensing Deal with Pfizer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/910e3273f066dff01138c9aa07302f76 |
|
| 2010-12-23 15:11:00 |
Share Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/33d96cc4a6a1d2b976364f3992348441 |
|
| 2011-01-13 13:43:00 |
Phylogica Accesses Novel Half-Life Extension Technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6cfd65c1fa751d3ed6bd1df9dbd9ca0c |
|
| 2011-01-24 10:23:00 |
Phylogica Receives Prestigious Frost and Sullivan Award |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bf1d126b693571a279ac574ea62343a9 |
Company Administration - Other
|
| 2011-01-25 09:37:00 |
Phylogica Named as One of Bioshares `Top 10 Picks` for 2011 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/75827c4ce0633c2574ae7f7397a9f34d |
Company Administration - Other
|
| 2011-01-28 17:47:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/84310870659e1e75686d25d9d48ad7d3 |
Commitments Test Entity - Second Quarter Report
|
| 2011-02-03 18:07:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/624deb11f598b1f0c59ba21ba041fae7 |
Change in substantial holding
|
| 2011-02-03 19:14:00 |
Change of Substantial Holding - Correction |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b45815c00caef72205f6c2bc48c9d10e |
Change in substantial holding
|
| 2011-02-07 09:46:00 |
Shareholder Update February 2011 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc0cc6eaada57c9f65e9249b6618bc3a |
|
| 2011-02-17 10:31:00 |
FNN interview N Woolf Pfizer Deal, Goals for 2011 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fb51051a5eb92f6f5fba556da48d4eb2 |
|
| 2011-02-17 10:32:00 |
Phylogica Announces Successful Collaboration with Roche |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5a528b2a40bcaa43f926de6da625caed |
|
| 2011-02-21 09:45:00 |
Phylogica - New Potential For Treating Brain Injury |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa360a91b9b690ac0fdf8ee3ed12b555 |
|
| 2011-02-22 12:42:00 |
Change in substantial holding from BTC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a72fced141ae923f2e59203ebc2a89c |
Change in substantial holding
|
| 2011-02-22 15:07:00 |
Clarification of change in substantial holding in PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1f2d24d1b7ded56b0aa03dc2040a5f6 |
Change in substantial holding
|
| 2011-02-23 09:43:00 |
Phylogica - Isogenica Technology Collaboration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f330328c77a3f8afa85a628954ded9cc |
|
| 2011-02-24 13:28:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9947ed4fd05421ff490689770d4afcfd |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2011-03-03 17:47:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c29b6e29dcb169659c02346258d749c4 |
|
| 2011-03-09 09:46:00 |
Phylogica Discovery Spin-Off with University of Cambridge |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dbd18d9d8fedaaad367f63c0d9c46c6f |
|
| 2011-03-15 12:44:00 |
Shareholder Update March 2011 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/189992975efce4d5a182f903050908bd |
|
| 2011-03-23 09:28:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e4c01b4555fde3447038c64b3f4e0ff4 |
|
| 2011-03-25 09:24:00 |
Phylogica Limited Share Placement raises $5.2 million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9e68521b4cb507a28466b7e1bf618ea6 |
|
| 2011-03-25 14:34:00 |
Appendix 3B first tranche placement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb5c9d00388ed59222c8dc50d1b0b0a0 |
|
| 2011-03-30 14:57:00 |
Cleansing disclosure document |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfe57c942d361d318d3db8bd9e3d220e |
|
| 2011-04-01 11:23:00 |
Appendix 3B 1st Tranche A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0156ff3f09645f3d56e25e7864d6056e |
|
| 2011-04-04 10:57:00 |
Appendix 3B 1st Tranche B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0522a48ceb077aead59baea520a4e470 |
|
| 2011-04-05 11:24:00 |
Corporate Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40637187e605701565671b6047f6fa7a |
Details of Registered office address
Company Secretary Appointment/Resignation
|
| 2011-04-08 17:56:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3968815753ce9c07e351928e9d2d9d28 |
Notice of General Meeting
|
| 2011-04-11 12:08:00 |
New US Screening Patent Granted |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3829f581a2a49a9fcb3b8b758dc381c |
|
| 2011-04-29 11:26:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6100bd35900bb1ffc126bd9cec828979 |
Commitments Test Entity - Third Quarter Report
|
| 2011-05-05 11:28:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f112dfe6887b7e71277261f06c78b90 |
|
| 2011-05-10 09:18:00 |
Collaboration with PEPSCAN |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7609e3ae7177f5f103f90cac3fcbd30b |
|
| 2011-05-10 12:31:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/675c59983c85163395bb3e17cc84bbe2 |
|
| 2011-05-11 14:35:00 |
Ceasing to be a substantial holder from BTC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/11a220fa7d23afdaf7dacba380bd4bab |
Ceasing to be a substantial holder
|
| 2011-05-16 16:07:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7def163d8c9eb85be5fca1bef37f0f67 |
|
| 2011-05-18 16:57:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6aa02ec4d7fb5e64b3abb96d8bd46556 |
Becoming a substantial holder
|
| 2011-05-19 11:37:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c8a21059c1777364db944dcac464528 |
Change of Director's Interest Notice
|
| 2011-05-19 11:37:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72831d41cf99d09b39f4798ab20b4df1 |
Change of Director's Interest Notice
|
| 2011-05-19 11:39:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e2b260aa205081bde6939010efaa4b3f |
Change of Director's Interest Notice
|
| 2011-05-20 13:45:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d0cbc3a9ad71b557a3d5c1009b1c693 |
Change in substantial holding
|
| 2011-05-23 09:24:00 |
Roche Collaboration Extended |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2433f18f4afbef473e99246aed64bc30 |
|
| 2011-05-23 17:51:00 |
Response to ASX Query |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6200c114f24a44eda0cb2cdcadd64f08 |
|
| 2011-05-25 10:10:00 |
Progress on Cell Penetrating Peptides |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38dfa7ba8c9c1daa9f4ab878432c5dd4 |
|
| 2011-05-26 15:38:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c5bcf7dfb8ed43483cb669f1b349b7b |
Change in substantial holding
|
| 2011-06-10 08:29:00 |
NAOS Asset Management 10.2% shareholder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9138abc73e6fcd31994ccc9e7d7e5f68 |
Security holder details - Other
|
| 2011-06-20 13:39:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/313169b2c7073b36bc17bd42d8e1dc72 |
Change in substantial holding
|
| 2011-07-08 12:56:00 |
Edison Investment Research Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2eef99221797e25eff9462992d4ad359 |
Company Administration - Other
|
| 2011-07-27 14:10:00 |
Letter to Optionholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76cdeb90e31e943319e4d9cfd44f4a37 |
Letter to Shareholders - Other
|
| 2011-07-29 18:21:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dbc1a39e2b77b38f99ba7d5fee99816c |
Commitments Test Entity - Fourth Quarter Report
|
| 2011-08-01 12:15:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cf9f21a529c7e69f57538843bf63ea88 |
Change of Director's Interest Notice
|
| 2011-08-01 12:15:00 |
Expiry of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea99786ce78e1cdb571f838623cf1768 |
|
| 2011-08-19 10:11:00 |
Life Sciences Showcase 2011 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a957b2ec41bf237057421e5a2934a1ee |
|
| 2011-08-31 10:15:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f211f73ce9753948404a51697d75fb23 |
|
| 2011-09-01 15:32:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f068df0be3980386493a26695de697ab |
Change of Director's Interest Notice
|
| 2011-09-01 15:32:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4bf69341d6232e797a14a9c1dc0ffe8e |
Change of Director's Interest Notice
|
| 2011-09-01 18:25:00 |
Broker Research Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04a726f6c40de3ef6c8aca11cb4c6884 |
|
| 2011-09-05 16:36:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d59866f55a058391984d37f809e6a1f |
|
| 2011-09-27 17:22:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b922d70bf910ec6c1c8a355f4deb511 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2011-10-07 12:03:00 |
Details of Company Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e491e12d038845185ddd36bde668fe93 |
Details of Registered office address
|
| 2011-10-24 11:32:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71b886ee87ab4717a2919dd50ee316c7 |
Notice of Annual General Meeting
|
| 2011-10-24 11:33:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6aa791a117fa99eba5907078d3d2378a |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2011-11-01 08:23:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/064e198b9e74251d56d125249943c874 |
Commitments Test Entity - First Quarter Report
|
| 2011-11-21 14:26:00 |
MedImmune Antibiotic Discovery Partnership |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4b79e025c0b24d0c6d478362f0955d36 |
|
| 2011-11-24 12:41:00 |
Presentation to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee7f5cb46070f1a2d42eaf6f238a7b76 |
Chairman's Address to Shareholders
|
| 2011-11-24 14:42:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9efb8b834aa575805ea933f80ad3e099 |
|
| 2011-12-12 10:17:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7b5c66cfc0e005a2382f38f906b2b822 |
|
| 2011-12-12 10:52:00 |
Pfizer First Stage of Collaboration Complete |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b07252a7a3cf46e1eac66c1a693afc1f |
Asset Acquisition & Disposal - Other
|
| 2011-12-14 10:39:00 |
Share Placement raises $2.15 Million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5e9605d949574665048f0495a385aaf3 |
|
| 2011-12-16 17:30:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85c891070b0430f1447f62b1285a894b |
Ceasing to be a substantial holder
|
| 2011-12-21 14:05:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9c8ed1a5975c234db1525b251dc17c4 |
|
| 2011-12-21 14:07:00 |
Notice Under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/250e71d20c5ab6d1f85c271d22d2fa7b |
|
| 2012-01-03 09:16:00 |
Technology Licence to Janssen Biotech |
1 |
https://app.sharelinktechnologies.com/announcement/asx/da679b776e5020f7d2ad1457ea62af59 |
|
| 2012-01-03 09:31:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4cc47927bb83c978637752ab59e35b35 |
|
| 2012-01-05 11:46:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3d1ad30f44a9c1eeae357fb7193b1a8 |
Change of Director's Interest Notice
|
| 2012-01-12 13:23:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5a33ca25b2691ae2f25c8dba64d7424a |
Change of Director's Interest Notice
|
| 2012-01-13 13:31:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7485646d3bb56c22c53d1b7cf47980e8 |
Change in substantial holding
|
| 2012-01-31 09:21:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b053ec9e1a480d1b48e0aeec1463a37e |
Commitments Test Entity - Second Quarter Report
|
| 2012-01-31 17:45:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01b89472855020de22cb6884f36601e5 |
Ceasing to be a substantial holder
|
| 2012-02-02 08:26:00 |
NAOS Increases Shareholding to 11.5% |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6d0bc2b8436c864a9d896a93347952e3 |
Security holder details - Other
|
| 2012-02-22 15:20:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/014cbb4e6eab1a8b96e52ce91bb083a5 |
Change of Director's Interest Notice
|
| 2012-02-22 15:22:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c84008e9a68139022a2544510fa5c9a |
Change of Director's Interest Notice
|
| 2012-02-23 14:34:00 |
US Patent granted |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38d15cd84a84d29ccf0e7e3cabfee287 |
|
| 2012-02-27 08:21:00 |
Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f18c97279dffb4fd596e87b1343efb3 |
Half Year Directors' Statement
|
| 2012-03-01 09:42:00 |
Director appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c0f5a485de40d2a2cff65d2736042b0 |
Director Appointment/Resignation
|
| 2012-03-01 12:08:00 |
Initial Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f09da4c0d3d046c71586a5ea26b61d3 |
Initial Director's Interest Notice
|
| 2012-03-05 08:27:00 |
Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a3564ad26ce396cbfe39974ce8ac0d7 |
|
| 2012-04-04 17:11:00 |
Appendix 3B Issue of unlisted shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de816d0d800741aad926170c020beabb |
|
| 2012-04-04 17:11:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e1b9bd32871beb9102a163f4d8ed804 |
Change of Director's Interest Notice
|
| 2012-04-04 17:17:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da4cfb8eee2fa1ff5a6f5203041faa48 |
Change of Director's Interest Notice
|
| 2012-04-04 17:17:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f290e1ebcc41318e60c6b1d46c6a639 |
Change of Director's Interest Notice
|
| 2012-04-04 17:18:00 |
Change of Director`s Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12c5e30ee68cfdd811a9d7a44bf944a4 |
Change of Director's Interest Notice
|
| 2012-04-26 13:10:00 |
Patent Granted for Synthetic Phylomer Libraries |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8a9ec164ceb9f18fef152972bc263b93 |
|
| 2012-04-27 08:27:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5627484ca127b6c71041eb194a93d09f |
Commitments Test Entity - Third Quarter Report
|
| 2012-05-17 11:02:00 |
Analyst Investment Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01388aaa8bc5c692762caa1ab96c9af0 |
|
| 2012-05-31 10:44:00 |
Pfizer Research Project Milestone |
1 |
https://app.sharelinktechnologies.com/announcement/asx/091fbc9c3e7f7280210244356e6e3731 |
|
| 2012-06-06 14:29:00 |
Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/405231a8c478c2d9b764dde934148a39 |
|
| 2012-07-10 08:26:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b3d7f51dad89042dde5c529027d5a387 |
Commitments Test Entity - Fourth Quarter Report
|
| 2012-07-10 09:39:00 |
Shareholder newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac7c7e0332a3593ccf42f3fe340b0864 |
|
| 2012-08-09 11:40:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4eeed42b5b185e03dae82ebde96f110a |
Change of Director's Interest Notice
|
| 2012-08-21 08:24:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4fa271d62a7d465ac107442c10f1b7e2 |
Becoming a substantial holder
|
| 2012-08-21 15:39:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5610d56c7598495c6a52858aed0c4f28 |
|
| 2012-08-21 15:43:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd12907b80ee1d2c0003facbb16980f9 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2012-08-24 12:02:00 |
Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9e7791779e85565677888caaeb19010 |
Notice of Meeting - Other
|
| 2012-09-04 16:06:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/567b92ef0c839233b701935fe94a8aac |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2012-09-12 08:55:00 |
Phylomer licenced to Le metier de Beaute |
1 |
https://app.sharelinktechnologies.com/announcement/asx/af73473e582fcb8055bb73951c1affb7 |
|
| 2012-09-13 08:29:00 |
R&D tax offset refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b3cf13c12ca25066ce2206ce7aa2b46 |
|
| 2012-10-16 11:15:00 |
Converting Note Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2f09ee31f1013c83b5589f6185f41118 |
|
| 2012-10-18 12:54:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a93c1931aba9c1a0118142840890317 |
Notice of Annual General Meeting
|
| 2012-10-25 12:46:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8305ad250ac0571146421eecb2365aca |
Commitments Test Entity - First Quarter Report
|
| 2012-11-06 11:19:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99a0e466a8fce53370c4feb54fc7e2c3 |
Change in substantial holding
|
| 2012-11-19 08:29:00 |
Appendix 3B Unquoted ESOP Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/37484a89947a0d6956745876d18987ce |
|
| 2012-11-22 10:02:00 |
Phylomer Library Upgrade |
1 |
https://app.sharelinktechnologies.com/announcement/asx/25990845a52c2ef53d14a51ebca9863f |
|
| 2012-11-22 13:55:00 |
Annual General Meeting Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/390478174cf519906251c2e1e1538c5b |
Chairman's Address to Shareholders
|
| 2012-11-22 15:54:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f94107b5d02e52e9d045aa510133c249 |
|
| 2012-12-03 18:00:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9cc6e45e7e220492aa9264e737566a31 |
|
| 2012-12-03 18:00:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fcca0ee7b23b6f08f711cba8f193b468 |
Change of Director's Interest Notice
|
| 2012-12-03 18:00:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b2067467f2d8b9d16b81c7d8a2e5953 |
Change of Director's Interest Notice
|
| 2012-12-03 18:01:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e8919e65cb38adcdf0dd3d6b544473e |
Change of Director's Interest Notice
|
| 2012-12-05 17:02:00 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2295c00f0e8953c072cfe46010ce4ec8 |
Company Administration - Other
|
| 2012-12-17 12:42:00 |
Appendix 3B Correction |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7050f3e7452034f96cd9c773384c3d15 |
|
| 2013-01-31 13:41:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e33674ed208480a11b877da49b0fce92 |
Commitments Test Entity - Second Quarter Report
|
| 2013-01-31 13:41:00 |
Janssen Collaboration Extended |
1 |
https://app.sharelinktechnologies.com/announcement/asx/94b1a723d9e5aeb7cf1bf023a7136250 |
|
| 2013-02-05 11:52:00 |
Collaboration to Commercialise Anti Inflammatory Phylomers |
1 |
https://app.sharelinktechnologies.com/announcement/asx/af60a6c8ade53ba3b423644602c77be2 |
|
| 2013-02-20 19:05:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/874ef6c920f2ca41001c31e79246b4c8 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2013-03-14 08:25:00 |
Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00e9b7176d2031cbc20dd5ac4767bc0d |
|
| 2013-03-22 08:28:00 |
Core patent granted in Australia |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa75084e13733e7601a87c8ba4b2c8f5 |
|
| 2013-04-10 14:06:00 |
Phylogica Engages Financial Advisor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c803efd4611a86f4f78a8d328151e109 |
Company Administration - Other
|
| 2013-04-17 12:26:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1aed201fd05abaed6cd7e7c255c081b6 |
Commitments Test Entity - Third Quarter Report
|
| 2013-04-24 13:10:00 |
European Patent Granted |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5d00639994524a8b8e2c5990092e26c0 |
|
| 2013-05-06 13:44:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e650ecf29587fda283dc4505e48caa75 |
Change of Director's Interest Notice
|
| 2013-06-27 10:13:00 |
New Patent to Discover Sophisticated Cell Penetrating Drugs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/113137ab6cb084f93e14628252dba18f |
|
| 2013-07-01 09:58:00 |
Janssen Collaboration Expanded |
1 |
https://app.sharelinktechnologies.com/announcement/asx/83a36469e8fc9d261f37479b4602f6e4 |
|
| 2013-07-04 12:03:00 |
Grant Received for Phylomer Based Biosensor Device |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8290adfbef3025527305b6feea22930a |
Company Administration - Other
|
| 2013-07-19 09:38:00 |
CEO and Director Changes |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d8c50e23091a407a5d56fc50b20ceeaa |
Director Appointment/Resignation
|
| 2013-07-23 15:05:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/728af557a09859b15175985222e9adfa |
Final Director's Interest Notice
|
| 2013-07-23 15:06:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d1221d0e9a18acabbe4108f31b01168 |
Final Director's Interest Notice
|
| 2013-07-23 15:07:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ef54b902ae4782927b758e115e6cc21 |
Initial Director's Interest Notice
|
| 2013-07-25 11:23:00 |
Antimicrobial Phylomer Collaboration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa5afc369dac89c0eff8b5af70f3ddde |
|
| 2013-07-30 09:44:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9fa8169d9afdbe4bb9c8e17c2f532fd |
Commitments Test Entity - Fourth Quarter Report
|
| 2013-08-30 16:26:00 |
Appendix 4E and Audited Annual Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/96bc715d3e886c8ef11aa004b2b027ce |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2013-09-06 08:25:00 |
Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/145f0695925bd10563dcdeb03f8c402a |
|
| 2013-09-09 12:28:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/afb10753f0b4179a5b681bebce5c5ae2 |
Change of Director's Interest Notice
|
| 2013-10-02 09:08:00 |
US Patent Synthetic Phylomer Libraries |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cc0bc038ff9e33464b79a4feef191cb4 |
|
| 2013-10-25 08:25:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d6ad1283c1f29f70e523e8a0039fab82 |
Notice of Annual General Meeting
|
| 2013-10-28 12:51:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b886452935be3ef42a358fce31bb4b7 |
|
| 2013-10-31 09:08:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3699f3d6b6f4c08693c1a737b08e04ad |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2013-10-31 17:43:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/df8e159b3ee2de5f748806c6864d17e9 |
Commitments Test Entity - First Quarter Report
|
| 2013-11-01 08:16:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/257546161155113d478531dbde96cb2d |
Change in substantial holding
|
| 2013-11-07 09:46:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/496f19ce8194efcc600c82c45ee9bdc9 |
|
| 2013-11-11 09:45:00 |
Entitlement Issue and Note Conversion |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bb22418622b8af6bd3167d6e763b652a |
|
| 2013-11-11 19:15:00 |
Application for listing employee share plan allocation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/91a1be132b9255c81d7b0499badba27e |
|
| 2013-11-13 11:47:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a40f127950b43a8b4ee8e9d9e8ebb5d4 |
|
| 2013-11-13 13:52:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2dcf9aed3b6839739ba1a70064fed3b3 |
|
| 2013-11-13 15:36:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7eea0251a69e8b0b32606720fae23558 |
Change in substantial holding
|
| 2013-11-14 13:04:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/000eb4895000166cc115c43599c3f50c |
Change of Director's Interest Notice
|
| 2013-11-14 13:04:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb3542de096b775f5223266f6957e0dd |
Change of Director's Interest Notice
|
| 2013-11-18 09:29:00 |
Recapitalisation update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e59057eb03469bc84931c18915b6d09 |
|
| 2013-11-25 09:44:00 |
Rights Issue Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d81a67345c1ec601e12d4876b6f2a9a |
|
| 2013-11-28 11:49:00 |
Presentation to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/381d97637e568d2f5d6b38a08ed4afd7 |
Chairman's Address to Shareholders
|
| 2013-11-28 13:45:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac4483c427f53003a9c53b82ad6fc41a |
|
| 2013-12-02 16:49:00 |
Entitlement Issue Offer Document |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a0e3ce522d62fdacdf7471fdf41dede4 |
|
| 2013-12-02 16:50:00 |
Entitlement Issue Application for Listing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61db4411c5723066325e5b638549e884 |
|
| 2013-12-02 16:51:00 |
Entitlement Issue S708AA Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/595d403a58e035ed8a830c2a45543e66 |
|
| 2013-12-03 11:57:00 |
Additional 708A Notice - Note Conversion |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9aad600d31b3d326f2b4d543a640d45d |
|
| 2013-12-03 11:58:00 |
Option Expiry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1caf7d776ca90cf6fd03eb3b927c40e9 |
|
| 2013-12-03 17:23:00 |
Letter to Eligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0bdda237f666f82e0b3c4293ed89ee6c |
|
| 2013-12-03 17:24:00 |
Letter to Ineligble Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc156d118f6f45ac217914e21714930d |
|
| 2013-12-03 17:25:00 |
Letter to Optionholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d6ceca14505cd562d8eb06c0c31358d |
|
| 2013-12-12 18:55:00 |
Offer Document Despatch |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d611bf8da13dff0814aaf60f3c7ebe3 |
Company Administration - Other
|
| 2014-01-03 18:17:00 |
Response to ASX Price and Volume Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/660b182407c973e64664670804c8ef40 |
|
| 2014-01-03 18:27:00 |
Entitlement Issue Result and Shortfall |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f9d6a0d1f7c75db20ed00ded7402a86e |
|
| 2014-01-09 12:48:00 |
Change of Director's Interest Notice Hopkins |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88ac2d7496f5156843bcf43d5c3726aa |
Change of Director's Interest Notice
|
| 2014-01-09 12:49:00 |
Change of Director's Interest Notice McHarrie |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1fab205c04e9ed2d0d423e2bd9d9d6af |
Change of Director's Interest Notice
|
| 2014-01-09 12:49:00 |
Change of Director's Interest Notice Wilson |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45d259f0f4511bad76a9b0c9e12a0edc |
Change of Director's Interest Notice
|
| 2014-01-09 14:26:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0f09f1ff4f96b61e58d124074c0b846 |
Change in substantial holding
|
| 2014-01-24 09:52:00 |
Director Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb736e4a13bf45f92bac699e9512d90e |
Director Appointment/Resignation
|
| 2014-01-24 11:38:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/23ec4712b76342203a2177fa7e03b3c6 |
Initial Director's Interest Notice
|
| 2014-01-31 17:12:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0730f9723b73f7a4f5e1f7b31db22691 |
Commitments Test Entity - Second Quarter Report
|
| 2014-02-07 16:34:00 |
Response to ASX price query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa4b90780c987b4e3a7aaf7d0e049b41 |
|
| 2014-02-28 11:42:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c7a13dbe9f8b365abf55c63b212069dd |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2014-03-03 11:15:00 |
Investor presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e01a00882f8164a7cb3c0e027fb95cd3 |
|
| 2014-04-07 09:15:00 |
Shareholder Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e1fb2da4cb910acea93fed78baefbdcc |
|
| 2014-04-29 12:59:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bae80c9f2f078d7b69af220ab1ac5d7f |
Commitments Test Entity - Third Quarter Report
|
| 2014-05-12 14:53:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6b1f7fb6f77349d9fd095d6f7216eec |
Change in substantial holding
|
| 2014-05-16 11:57:00 |
Shareholder Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7fa1518bf1ad1d1f7caa75faf2b8c627 |
|
| 2014-05-19 16:32:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad68334fc717b207c35ba982f994f922 |
Becoming a substantial holder
|
| 2014-05-22 18:52:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0b147652a5ceb38634fe7847920b495a |
Change in substantial holding
|
| 2014-07-29 12:00:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b6eec34d403c7585fbf34eb8327dca61 |
Commitments Test Entity - Fourth Quarter Report
|
| 2014-08-18 10:28:00 |
Research Service Agreement with Genentech |
0 |
https://app.sharelinktechnologies.com/announcement/asx/949ccb623d6124e333603e843965a12c |
Company Administration - Other
|
| 2014-08-28 10:43:00 |
Phylogica Patents Granted |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3dded7f4a3b4ff27ca3983afa3a09cf9 |
|
| 2014-08-28 17:31:00 |
Appendix 4E and Audited Annual Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/095d525ff411eac1437d8577d10ef72f |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2014-09-02 08:26:00 |
Grant for Cancer Drug Research |
1 |
https://app.sharelinktechnologies.com/announcement/asx/380ad29f84387d04ddf8e7227c8b6517 |
|
| 2014-09-18 11:45:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b4c7747640537c6acc481eccd057dcd |
|
| 2014-10-09 11:35:00 |
Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/969665836473712362f77e7eb031db47 |
Notice of Meeting - Other
|
| 2014-10-21 16:21:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a19f6214b98269cbe82eaa3169824aa9 |
Notice of Annual General Meeting
|
| 2014-10-21 16:21:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35bd04e5180cd0707d49a3dabff3db58 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2014-10-23 17:35:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dce02000471eb2810d3bfe230a449fc9 |
Change in substantial holding
|
| 2014-10-31 12:45:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bcff425868f0366d5870da40a741f2d2 |
Change of Director's Interest Notice
|
| 2014-10-31 12:46:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8565a378d4131704bdc06321ce418df0 |
Change in substantial holding
|
| 2014-10-31 14:58:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/04eb36833aa75141a01d9099c1c5e547 |
Commitments Test Entity - First Quarter Report
|
| 2014-11-05 12:10:00 |
R&D Tax Rebate |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f2e2fbb3fd8cb6a168105f3b3b3d7f9a |
Company Administration - Other
|
| 2014-11-06 11:51:00 |
Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b78a32dfbe7606fdcf0094b168149524 |
|
| 2014-11-13 17:07:00 |
Bioshares Article |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4eaeadd2579998673f31e6ef0b701cb |
|
| 2014-11-14 14:26:00 |
Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48f9d88118f4e7d1921b6461a25c2be5 |
|
| 2014-11-25 09:43:00 |
European Patent Synthetic Phylomers |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de69a56979c5560dd751b8606a6c0354 |
|
| 2014-11-27 16:15:00 |
AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/169e422ca2416b6e3dc9999ff47d2f42 |
Chairman's Address to Shareholders
|
| 2014-11-27 18:37:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c446d4e7382c369ebe0a7375594f4c43 |
|
| 2014-12-22 09:11:00 |
Licensing Agreement with Genentech / Roche |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ab742980ce9e0c51efb5d525f59a4999 |
|
| 2014-12-24 14:20:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c88fcd13dce83451997e0f5552c9ac2 |
|
| 2014-12-24 14:21:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5cfc844738594e5f6a94e8b61693bb40 |
Change of Director's Interest Notice
|
| 2015-01-15 11:21:00 |
Phylogica to present at Biotech Showcase Event in US |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d034214890f066f0344526229f62a07 |
|
| 2015-01-30 11:29:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/97217efb8bd0686a2004d5f5ee5f7ba9 |
Commitments Test Entity - Second Quarter Report
|
| 2015-02-17 11:18:00 |
Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1bdaf9b4e3aadeca7294b308c76a0f48 |
|
| 2015-02-24 09:50:00 |
Europe Patent Phenotypic Screening |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1eaaf2b6b3217793b55a720c3e90ac6c |
|
| 2015-02-27 12:56:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/488d3a046c3aa40da26b8d2de121640a |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2015-03-02 17:47:00 |
Response to ASX Query - Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b380b8d920163280d0216f641164aea2 |
|
| 2015-03-27 13:36:00 |
Joint Company Secretary Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4683363628020382a2d2a80c22cf75cb |
Company Secretary Appointment/Resignation
|
| 2015-03-30 10:28:00 |
Cancer pilot study success |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53b2e10d732be63314a7bcf1b962b790 |
|
| 2015-04-07 09:55:00 |
Phylogica licenses peptides to UK company |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b87d9a1adb410f782becd8dc317aed00 |
|
| 2015-04-09 10:27:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c402f3952c4ec1edfaca0f00abfc193a |
|
| 2015-04-15 17:18:00 |
CEO Interview and Article |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3da0dd455ae9cc63a3714bcc6ce83118 |
Company Administration - Other
|
| 2015-04-30 11:31:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98c7f11449d49227cd56072d13f3ad3a |
Commitments Test Entity - Third Quarter Report
|
| 2015-05-01 11:45:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48b54f0a8f7fd3f24fd8912f8adb1220 |
|
| 2015-05-27 11:00:00 |
Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc90420960638ebfd2b43a416789dd04 |
|
| 2015-07-02 09:04:00 |
Entitlement Issue |
1 |
https://app.sharelinktechnologies.com/announcement/asx/170610e983106c021f53f87b02a0e83d |
|
| 2015-07-02 13:36:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2cb8e761625308b896e3d777858d51c0 |
|
| 2015-07-02 13:36:00 |
Entitlement Issue Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d4c3ee67791148e5df8a0acae31820ba |
|
| 2015-07-03 10:36:00 |
Letter to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c89710ccd5ca6b768ad313467184da9a |
|
| 2015-07-03 10:37:00 |
Letter to Option Holders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3575261877c49e11b3516a51c7af9b2f |
|
| 2015-07-14 12:59:00 |
Despatch of Entitlement Issue Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/725f55558be3b73dbe00b086bab64354 |
|
| 2015-07-17 10:19:00 |
Australian Research Council Grant |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3cc3f4f6b79d585bafaa99f966209547 |
|
| 2015-07-20 09:38:00 |
Entitlement Issue Closing Date Extended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/08b05a61edfa9103a811b77773f7a8dc |
|
| 2015-07-20 12:35:00 |
Corrected Timetable - Non-Renounceable Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c12fabbd05048d8e60070f098b17fa72 |
|
| 2015-07-23 17:13:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45571e2cd2129daee53cb934913a9d70 |
Change of Director's Interest Notice
|
| 2015-07-28 09:16:00 |
Issue Closing Date Extended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c49a991d6e169f2abd3d7b42febd06b |
|
| 2015-07-28 15:02:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb50dc34e45fc197827ce57c390a97df |
Change of Director's Interest Notice
|
| 2015-07-28 15:31:00 |
Response to Appendix 3Y query |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f640a0208cc6d8413c05e0adcc3cba65 |
|
| 2015-07-31 10:16:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/639ebca81f7bd7b565320d42fc85201c |
Change of Director's Interest Notice
|
| 2015-07-31 10:21:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c6d64588f71db1b035c22a002e71c9d9 |
Commitments Test Entity - Fourth Quarter Report
|
| 2015-08-04 18:11:00 |
Entitlement Issue Supplementary Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f5cfd3230df41cc8be98fb7b60d7caef |
|
| 2015-08-11 14:04:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9059637b83f3b343b17da4e52df0403 |
Change of Director's Interest Notice
|
| 2015-08-11 17:26:00 |
Entitlement Issue Result and Shortfall |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ef58cc2670e5bcba9b49ae992906ae0 |
|
| 2015-08-14 15:00:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/934f6e55e6ef33f7c36b93c3b4a9368b |
Change of Director's Interest Notice
|
| 2015-08-14 15:03:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a9f541e160618376a6f08f20864082d |
Change of Director's Interest Notice
|
| 2015-08-14 15:22:00 |
Top 20 Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2338f609b0ebde6234f33f2dee692e3 |
|
| 2015-08-14 16:09:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e348efab79be9b0142c5a6084972bde4 |
Change in substantial holding
|
| 2015-08-17 10:42:00 |
Expiry of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e4c417c688e3a4c3aba1999dcd2164e0 |
Alteration to issued capital
|
| 2015-08-17 10:42:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c14d3e95fb4fcbd1b410bba64d56c55c |
Change in substantial holding
|
| 2015-09-01 08:21:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b4588faab4c3ff54ba3a620baa6ef5d7 |
|
| 2015-09-29 13:05:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a6d2d5449c539f6858a710e1fad18ae6 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2015-10-01 17:23:00 |
Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a087ec48850f85713d92006a6c72cd38 |
|
| 2015-10-07 11:22:00 |
Annual General Meeting Date |
0 |
https://app.sharelinktechnologies.com/announcement/asx/220694d1e9c25dfcfc0add43f9116caf |
Notice of Meeting - Other
|
| 2015-10-08 17:39:00 |
Chairman Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63443c545aea6caf4001b73cb9cc4718 |
Director Appointment/Resignation
|
| 2015-10-23 18:06:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/91fae9d74efc69934012e2a87c5aa91a |
|
| 2015-10-23 18:06:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b9d85ab1d6048f028ff1c9117063c71 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2015-10-23 18:07:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3877291fa9edbb35b5f16a77650d13f |
Notice of Annual General Meeting
|
| 2015-10-30 14:22:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d80ac75393062cf5222cb73e9084b7a6 |
Commitments Test Entity - First Quarter Report
|
| 2015-11-05 08:26:00 |
Animal model cancer studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ab3bb9e6354b9ab0f5f4075ad6462d6 |
|
| 2015-11-13 17:07:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b4d32882fff082f82ec4a6041af5e0a |
Change of Director's Interest Notice
|
| 2015-11-16 08:31:00 |
Proprietary anti-cancer drug candidates |
1 |
https://app.sharelinktechnologies.com/announcement/asx/95811ac919692c36bd7f2d92eb668cb0 |
|
| 2015-11-17 13:19:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d26590e150ccc39144bcedafd1254fd |
|
| 2015-11-25 14:05:00 |
Presentation to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec51b6a44185534acca7ab632a26e727 |
Chairman's Address to Shareholders
|
| 2015-11-25 14:58:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/402b09829fa523fa558f0a505a524707 |
|
| 2015-11-27 18:42:00 |
Shareholder Briefings |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f82c4590833e497a722e2a8ab32483ad |
Notice of Meeting - Other
|
| 2015-12-09 11:58:00 |
Combination therapy escalates potency of Phylogica peptides |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b034ce6a165a42bb2887d58df3189bd1 |
|
| 2016-01-18 11:28:00 |
Director Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03aa1cf17f7e510f2827ab2029f564d1 |
Director Appointment/Resignation
|
| 2016-01-18 11:31:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/328823ac15f2cc41becff3674be834e0 |
Initial Director's Interest Notice
|
| 2016-01-29 11:41:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d166a6c252660f7336d907ef269fab39 |
Commitments Test Entity - Second Quarter Report
|
| 2016-03-01 08:24:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5e52e16510be42804a5272f85b3d0323 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2016-04-01 12:38:00 |
Investor presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d38c85fe349bf36e827152945f63fd8c |
|
| 2016-04-11 08:26:00 |
Chair Appointment and Director Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/46fd80aee0a3637bd0f55df5430b9bcf |
Director Appointment/Resignation
|
| 2016-04-12 10:47:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abca619c3ced3ef177527499b698e53e |
Final Director's Interest Notice
|
| 2016-04-29 16:58:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/549148b2d8891547f1ffe3c8ef01b320 |
Commitments Test Entity - Third Quarter Report
|
| 2016-05-23 08:25:00 |
Shareholder Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bc0849d149e776eebecddf96a9da3fa2 |
|
| 2016-05-26 11:06:00 |
Option Expiry Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e56ed7746f15c8e368d8329ed2f4c7ea |
|
| 2016-06-07 09:15:00 |
Conference presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0839615780cf6fab2d9aa3074843322 |
|
| 2016-06-15 09:59:00 |
Cell-Penetrating Phylomers Improve Delivery of Drugs |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15f5afcc52bb0313a90aaaff9edd8740 |
|
| 2016-07-01 16:28:00 |
Option Expiry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f30cc2e1f53d52b27f1766272f2407d |
Alteration to issued capital
|
| 2016-07-01 16:29:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/997d6e328e3bc3f6dcf51b63abdcbdc0 |
Change of Director's Interest Notice
|
| 2016-07-01 16:30:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea7e7cb225dc1daca6e102cfe9e39e03 |
Change of Director's Interest Notice
|
| 2016-07-18 17:19:00 |
Chief Executive Officer Resignation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/978d660291c3baf7c600e5bb6ddc2e72 |
Director Appointment/Resignation
|
| 2016-07-18 17:21:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51af2ff94e707cdf82e5f10885ddee36 |
Final Director's Interest Notice
|
| 2016-07-26 15:45:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/10d2d2fd5b98be0da4843b95da8ca47c |
Commitments Test Entity - Fourth Quarter Report
|
| 2016-07-27 12:34:00 |
Operational Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bde9317956c0b5bb96b8ac08f5ebae57 |
|
| 2016-08-15 16:50:00 |
Alternate Director Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4441dbbc1ff778ffc3515787f97f8c7e |
Director Appointment/Resignation
|
| 2016-08-15 16:51:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3546b1d8179f98bd62d393c6853ceed1 |
Initial Director's Interest Notice
|
| 2016-08-30 18:24:00 |
Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a6af6a012a5f5716302482712c5aec63 |
|
| 2016-08-30 18:25:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ece1d117c8d03dffe3bcc2247203fb99 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2016-08-30 18:27:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/911334cdb6f8b90856180d458d600125 |
|
| 2016-08-30 18:28:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cbe261b2acd6acfd56054e431ff7723d |
|
| 2016-09-12 16:04:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd79811577550eb622364abe4b30f159 |
Initial Director's Interest Notice
|
| 2016-09-12 16:04:00 |
Director Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca98057f01fcfbd106e23362bf7d5552 |
Director Appointment/Resignation
|
| 2016-09-30 09:09:00 |
Shareholder Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/639cf5a35b402a399ce5f694308ed213 |
Letter to Shareholders - Other
|
| 2016-10-10 13:26:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/601ad3f797a35aef56969b257464d157 |
Change of Director's Interest Notice
|
| 2016-10-14 14:42:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1f0d19e5b777a5de88b871e69aff9787 |
Change of Director's Interest Notice
|
| 2016-10-18 18:17:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/973f1c6c36e1c8ba2cb7e1b8f1ad3d0b |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2016-10-18 18:20:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3394ad2b1148d2b164e89fa21bf6080a |
Notice of Annual General Meeting
|
| 2016-10-31 13:00:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9d33d3a03fb9061238b62fa67441f699 |
Commitments Test Entity - First Quarter Report
|
| 2016-11-17 14:33:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f37d30568dcc22a91fab22b5431561fd |
Becoming a substantial holder
|
| 2016-11-25 16:24:00 |
Chair's Address to Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ada506e84e784b96ec267952c98c8a08 |
Chairman's Address to Shareholders
|
| 2016-11-25 16:24:00 |
AGM Presentation to Shareholders |
1 |
https://app.sharelinktechnologies.com/announcement/asx/71b4478259c626e4011c48848659c63b |
Chairman's Address to Shareholders
|
| 2016-11-28 08:25:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df22d0959829ae39f125c2862a6e5e18 |
|
| 2016-11-28 09:43:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4e06ccf13d2f7e1c679436692ed41bb |
Final Director's Interest Notice
|
| 2016-11-28 09:43:00 |
Director Resignation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67467ac3a8de1d8c78e07acea1980f84 |
Director Appointment/Resignation
|
| 2016-11-30 13:32:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eecb38def27f3e2a36173d3694c50cf5 |
|
| 2016-11-30 13:33:00 |
Change of Director's Interest Notice x2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/877058b2154a5dad496a75630816a5da |
Change of Director's Interest Notice
|
| 2016-12-05 11:33:00 |
NHMRC Grant Awarded to Collaborators |
1 |
https://app.sharelinktechnologies.com/announcement/asx/541ff260f5c67f3df56b3233d148329a |
|
| 2016-12-19 08:54:00 |
Genentech extends research collaboration period |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bac32345868f9ab136fad77df02a9ee7 |
|
| 2016-12-21 12:55:00 |
Operational Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/536475dad3029d02881de5e58ff57313 |
|
| 2016-12-22 15:01:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53933e1aedd947bc93c5febf0e5370a1 |
Change in substantial holding
|
| 2017-01-11 08:26:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/144110cba9573f9d6b024b8cebdd903b |
|
| 2017-01-24 11:50:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12c90a7b3f4daa010cb81f74404992d6 |
Change of Director's Interest Notice
|
| 2017-01-24 11:51:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8828b4346d83fe39209aa38cbb4cbdee |
Change in substantial holding
|
| 2017-01-24 11:51:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/75ec7fdcc761115ea02068f72299ad83 |
Change of Director's Interest Notice
|
| 2017-01-30 14:56:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/86bbdd013a16ca82730845a89897d4d4 |
|
| 2017-01-30 16:36:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bc10638c85ca15c794266a46ffdccb32 |
Commitments Test Entity - Second Quarter Report
|
| 2017-02-28 11:29:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/52b0d4ecfe4fcc7439550a1044ff6b66 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2017-03-10 13:05:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee6b6aadcffb978ab4437053b2318332 |
|
| 2017-03-10 13:06:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3a7b4bb851dcd077437d8a983f078ba |
Change of Director's Interest Notice
|
| 2017-03-10 13:06:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d563e3cbee968e30baec555ec9cad750 |
|
| 2017-03-13 16:20:00 |
ASIC Form 484 Share Cancellation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9a939c58d8876c332808ed1470e2331 |
Alteration to issued capital
|
| 2017-03-17 09:03:00 |
Clarification on Security Cancellations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4a682695b51f0b2dad141c4b29d580d |
Company Administration - Other
|
| 2017-03-31 18:06:00 |
Resignation of Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8abe9bf62bd3196008d29a7e720f4271 |
Company Secretary Appointment/Resignation
|
| 2017-04-03 08:58:00 |
New website released |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fec0a61b8263af7aee5abd908af3177a |
Company Administration - Other
|
| 2017-04-04 09:52:00 |
Operational Update March Quarter |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7c0160c5d9a90b9d292cecaaf02db216 |
|
| 2017-04-18 08:30:00 |
Board Renewal |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ce8610bea91c81587e774e33daa8e34 |
Director Appointment/Resignation
|
| 2017-04-18 15:06:00 |
Initial Director's Interest Notice (two directors) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69300f638a726c23d600070d85bade53 |
Initial Director's Interest Notice
|
| 2017-04-18 15:08:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/739aaf9ffbe4b92eeeb49cd99f7efbbb |
Final Director's Interest Notice
|
| 2017-04-26 13:40:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bfc16b6b431cd03a019634c8d3bb1d9c |
Commitments Test Entity - Third Quarter Report
|
| 2017-05-02 11:33:00 |
Appendix 3B application for listing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e24a54bed961435a512b5060c6942556 |
|
| 2017-05-02 11:37:00 |
S708A Notice for issue of shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c46955fb7f45ad7b243013e8105f236d |
|
| 2017-05-22 10:21:00 |
Appendix 3B application for listing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0bda9d1e1ba74a7dd5599dc176d36cb0 |
|
| 2017-05-22 10:27:00 |
S708A notice upon the issue of shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4cbbdbab2b3421741fde62023513d509 |
|
| 2017-05-22 10:51:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/83685096454337f9bbbef4e98b7a88bf |
Change of Director's Interest Notice
|
| 2017-05-25 16:30:00 |
Appendix 3B application for listing |
0 |
https://app.sharelinktechnologies.com/announcement/asx/66b99a771010982244fe4c2d6cb27019 |
|
| 2017-05-25 16:33:00 |
S 708(A) notice upon issue of shares |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9eb208182ac9efe0bda1d6ee6f58fffa |
|
| 2017-06-16 17:51:00 |
Application for listing $5m placement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56105589555950f2ac0f3ebb8b30ff6e |
|
| 2017-06-16 17:58:00 |
Share issue S708A cleansing notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49826cc3657aac818a3572bcf5db1e99 |
|
| 2017-06-19 09:35:00 |
CEO and CSO Appointments |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a70309c24701b83b19f8cdcdfde629be |
Director Appointment/Resignation
Company Administration - Other
|
| 2017-06-19 17:58:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c0dcafcba28d7f2fe5f482f5b1f226f |
Change of Director's Interest Notice
|
| 2017-06-19 18:12:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0c438d2274a57e47b95f1ae86e0ac3a |
Change in substantial holding
|
| 2017-06-20 10:18:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f3ec07e3149f99aaa7f437187412c1e |
Change in substantial holding
|
| 2017-06-20 10:19:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/850a1fdd97d2890a09d8db243c15bafc |
Ceasing to be a substantial holder
|
| 2017-06-20 13:56:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/787a07d1300a7230d7b8a7dc9060df8d |
Becoming a substantial holder
|
| 2017-06-20 16:35:00 |
Executive Director Remuneration |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c99ffefec52d5595d6798f60acd536d5 |
Company Administration - Other
|
| 2017-06-28 08:25:00 |
S708 Cleansing Notice option issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be054e320df03018ed78afd1e9425b0d |
|
| 2017-06-28 08:25:00 |
Appendix 3B option exercise |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6681d5a1f052c2b55c06613aa072a5f5 |
|
| 2017-07-04 13:23:00 |
Application for listing upon option exercise |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fed3b7edc28ef38e073ebc102b4da0e1 |
|
| 2017-07-04 13:24:00 |
S 708A cleansing notice for option exercise |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba378dd341e261309d43b2aa58cf2414 |
|
| 2017-07-11 08:55:00 |
Operational Update June quarter |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0657cfed0d8f49ac8345a73a242c3efe |
Director Appointment/Resignation
|
| 2017-07-24 13:10:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/31d9238edd42ff12d39a9962cbf924b0 |
|
| 2017-07-24 18:05:00 |
Change of Company Secretary and Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2becfdb4c61fd9a52594fce02e72201a |
Details of Registered office address
Company Secretary Appointment/Resignation
|
| 2017-07-31 16:12:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8d4dd307a87e5277e263547ff9ab7727 |
Commitments Test Entity - Fourth Quarter Report
|
| 2017-08-18 17:17:00 |
Phylogica Investor Briefing - August 2017 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/429598a8f1b25f43346c4df16fdd5903 |
|
| 2017-08-21 08:51:00 |
Phylogica Investor Briefing - August 2017 Amended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed19a4e9e6092ee5af2279caac96a752 |
|
| 2017-08-31 17:49:00 |
Appendix 4E - Preliminary Final Report 30 June 2017 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8a569b5636f2090579d5d33abeebd04b |
|
| 2017-09-01 10:45:00 |
Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42f9eeb568647bf7ebc3fbc9cca8631b |
|
| 2017-09-05 11:50:00 |
New Delivery Vehicles Show Improved Performance Inside Cells |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7172f8809e98546820f3a6a3672e7eae |
|
| 2017-09-12 08:20:00 |
Sydney Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9938e80bf4666aab95adc62a954701f5 |
|
| 2017-09-20 11:27:00 |
Finance News Network Interview with the CEO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dff83c9f23e1dd107613dbc427e37a65 |
|
| 2017-09-22 14:29:00 |
June 2017 Annual Financial Statements |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2e8ae01bc4fbb47e80613a48f9145ef6 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2017-10-02 17:15:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a651865c379f7b3252f5846efac0a6c5 |
|
| 2017-10-04 13:19:00 |
PYC Granted US Patent for Peptides Entering Brain Cells |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8f788c96ae656488678cbe48a837f806 |
|
| 2017-10-09 08:18:00 |
Investor Presentation - October 2017 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4a642dbd1b952a323a7602f86ea3eedb |
|
| 2017-10-19 18:20:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9a7809c380a645fd762a9f4ae0d8ead1 |
Change in substantial holding
|
| 2017-10-23 15:39:00 |
Appointment of Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/13c67fad2a5827de7b5666d6eed32442 |
Director Appointment/Resignation
|
| 2017-10-24 11:15:00 |
Research Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8218ab497e2103dfc61395c214823fcd |
|
| 2017-10-24 17:01:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b7ca011f400481380597a7e6049fd2f |
Becoming a substantial holder
|
| 2017-10-25 10:51:00 |
Establishment and Appointments to Scientific Advisory Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ac8097f7f8262587b6a70a2359101823 |
Company Administration - Other
|
| 2017-10-25 12:29:00 |
Quarterly Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/500f738d02188c371902a13067bea7af |
Commitments Test Entity - First Quarter Report
|
| 2017-10-26 16:31:00 |
Appendix 3B and Appendix 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bbb7a3e641547da637ab5dc98edc002c |
Change of Director's Interest Notice
|
| 2017-10-26 16:31:00 |
Appendix 3X and Appendix 3Z |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0aa3a27c27b5b6101be6fdad25b975d |
Initial Director's Interest Notice
Final Director's Interest Notice
|
| 2017-10-26 16:50:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d88f23ce1956cce750dbf0562a18c74 |
Notice of Annual General Meeting
|
| 2017-10-31 16:49:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/503d73a497b3f87d20963309465e9f18 |
|
| 2017-10-31 16:49:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f14ac90778c4a042d3b46e9e7e3a354 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2017-10-31 16:50:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ad45eabe3567c037587438b5afc7623 |
|
| 2017-11-06 11:45:00 |
Company Presentation- BIO Europe November 2017 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/439e99b70f6ac9ae58944a3f245e5cc5 |
|
| 2017-11-21 09:35:00 |
Paul Watt Joins Phylogica Scientific Advisory Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4d013b8c6c2dea23daae1526f47571e |
Director Appointment/Resignation
Company Administration - Other
|
| 2017-11-24 19:04:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d31a23c73e42d2670cdf8bd311293ce2 |
|
| 2017-11-27 09:17:00 |
Chairman's Address - 2017 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7612c473383be23d66605d5b3c3da62d |
Chairman's Address to Shareholders
|
| 2017-11-27 09:22:00 |
Company Presentation - 2017 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e5f93c0a4afd29054de0ec54efd473b |
|
| 2017-11-30 16:12:00 |
Appendix 3B and 3Y's |
0 |
https://app.sharelinktechnologies.com/announcement/asx/35f411c70a6349f6e653b740f52b537e |
Change of Director's Interest Notice
|
| 2017-12-01 19:10:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f95d9ed0d3711bf2b988a483f4d861e3 |
Final Director's Interest Notice
|
| 2017-12-04 09:29:00 |
Phylogica Strategic Update - Pivot to Platform |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9c95bc89e5c92abf6c640179116789d |
|
| 2018-01-03 09:48:00 |
Appointment of Non-Executive Director and Appendix 3X |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c72493f9991345a021ee3144e9087391 |
Initial Director's Interest Notice
Director Appointment/Resignation
|
| 2018-01-05 17:02:00 |
Appendix 3B and 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0fd63236b1c2939e2d969136bfad7d41 |
Change of Director's Interest Notice
|
| 2018-01-08 13:40:00 |
FPP Results Effective in Delivering Peptide Cancer Vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d8e409e3c4a325970c0012d0b99e62f9 |
|
| 2018-01-09 09:29:00 |
PYC Pivot to Platform - BioShowcase Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/07e5dca710a441fe5a7ac0e334f5df97 |
|
| 2018-01-11 13:25:00 |
Federal R&D Tax Credit Received |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8f40a587ec8064085b57a781ca9ab72 |
|
| 2018-01-12 11:35:00 |
Phylogica Appoints New Scientific Advisory Board Member |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5c43173e4e4645a839bbd55201a56651 |
Company Administration - Other
|
| 2018-01-31 15:02:00 |
Dec Quarterly Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ea2e85703810896478361d266c4a544 |
Commitments Test Entity - Second Quarter Report
|
| 2018-02-28 17:20:00 |
Dec 2017 Half-year financial statements & Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ba990bc1de78bbf02a70e8ba462abf4 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2018-03-02 09:54:00 |
Cre Enzyme Delivery Provides Validation & Strategic Value |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fbf10842138b403a1b76dab6d3d433fe |
|
| 2018-04-09 09:36:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/349ca5f2b0751e26a22789caa2da90ca |
|
| 2018-04-11 09:27:00 |
Notice of Change of Interest of Substantial Shareholder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43010b443032b1812ed8c6fb77c5203d |
Change in substantial holding
|
| 2018-04-11 09:29:00 |
Notice of Change of Interest of Substantial Shareholder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c303c7da6d6da39852326e58009f9b03 |
Change in substantial holding
|
| 2018-04-11 09:43:00 |
Changes to Board and Management |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2eb2cd2720febda3ca2aebcf640d8bc8 |
Director Appointment/Resignation
Company Administration - Other
|
| 2018-04-12 15:39:00 |
Initial and Change of Director's Interest Notices |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ccacceffd4d84f0cab33391174584c6f |
Initial Director's Interest Notice
Change of Director's Interest Notice
|
| 2018-04-30 14:47:00 |
March 2018 Operational Update and Cashflow |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8df29daa9973ae7ac1bc81594fb7181 |
Commitments Test Entity - Third Quarter Report
|
| 2018-04-30 18:29:00 |
March Quarter Investor Call Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/016043409e2cad9820ce39d64502e880 |
|
| 2018-05-02 14:48:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0d106f9ffe82caad3275b9618f67042 |
Final Director's Interest Notice
|
| 2018-05-03 15:50:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6be2aac8aa7f3b304d846aa5bb439a5a |
|
| 2018-05-03 15:52:00 |
Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/662c1bcbd33c6b70d423567a36e3dca2 |
|
| 2018-05-11 08:25:00 |
Investor Presentation - May 2018 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c69c1f0c2fe22dc5c9fc6c163b0f88b |
|
| 2018-06-29 17:43:00 |
Chief Executive Officer Employment Terms |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c600ec8f6aaf7d2ef0ce076a3c727c42 |
Company Administration - Other
|
| 2018-07-09 08:23:00 |
CEO Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/32232ad4f28badbbceeb85a8c02841eb |
|
| 2018-07-10 14:25:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/389cc048fa61ac219a11ef11c3466bee |
Change in substantial holding
|
| 2018-07-16 09:52:00 |
Peer Reviewed Journal Publication |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e19886933533c0e27483ec8f4d385c19 |
|
| 2018-07-27 09:13:00 |
Successful In-vivo Results Peptide Vaccine T-Cell Expansion |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f7117e1912be4a3f2dd4657adde13852 |
|
| 2018-07-30 10:07:00 |
Achievement of Major Milestone - In vivo Cre Delivery |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a32e9aeecf8a1ffeb32d5f65d633ddd1 |
|
| 2018-07-31 14:19:00 |
June 2018 Quarterly Operational Update and App4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8b985489ac58c689f8e0cbfbd6a0e200 |
Commitments Test Entity - Fourth Quarter Report
|
| 2018-08-06 12:55:00 |
Delivering Cancer Treatment Inside Cells - Nature Oncogene |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81a5ca6be3843e9cc9a6ec82e77c4431 |
|
| 2018-08-23 12:10:00 |
Phylogicas platform described in Nature Scientific Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90d99107f81f0b2abe2764a0df6813c9 |
Company Administration - Other
|
| 2018-08-31 13:46:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3c730ae69aa4597589df1f24e747b9a2 |
|
| 2018-09-07 09:25:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2d45d483833725584ca0c6ed7ff5b5a6 |
|
| 2018-09-11 09:18:00 |
Suspension from Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/27e400b34d2e49e02862112a0d275850 |
Suspension from Official Quotation
|
| 2018-09-11 09:49:00 |
Update on Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6a3c8212bdf4c87e3980396501c7e8ee |
|
| 2018-09-12 09:33:00 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9c647f7e7c18dd11461c642d59d9b217 |
Reinstatement to Official Quotation
|
| 2018-09-12 09:33:00 |
Phylogica Recapitalisation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8083824371cc0338bd1ff33ded6c6533 |
|
| 2018-09-21 15:58:00 |
Annual Financial Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3124b5008f5d7496fe088ecdacb97ab5 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2018-09-21 17:26:00 |
Appendix 3B and Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/724586ba84cc3eee90e216d7a5e1753c |
|
| 2018-09-21 17:27:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/58896410f4311692dd3d783383d96a39 |
Change of Director's Interest Notice
|
| 2018-10-08 17:45:00 |
R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/65e32eebca9e57357e0c6df76e9deef9 |
Company Administration - Other
|
| 2018-10-15 17:33:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5eab8561ac605a408bb0c4bc83d4a70 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2018-10-15 17:35:00 |
Corporate Governance Statement and Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b375a58c5a458b17fa88cea799ba2d0 |
|
| 2018-10-15 17:36:00 |
Notice of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63f5c8ed6a86d1966eb409da34158b29 |
Notice of Annual General Meeting
|
| 2018-10-29 15:20:00 |
Fourfold Delivery Improvement in a New Lead Candidate |
1 |
https://app.sharelinktechnologies.com/announcement/asx/236d8117d30276fd94a6e4a0be612eda |
|
| 2018-10-31 14:39:00 |
Sept 2018 Quarterly Operations Update and App4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f55b98e3373313373082e06f1dbc509d |
Commitments Test Entity - First Quarter Report
|
| 2018-11-16 14:24:00 |
AGM Company Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6eaa47b561f1b22c236def31eddd079e |
|
| 2018-11-16 19:49:00 |
Chairman's AGM Address and Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ead6e8830e07249c752195ac58f5745 |
Chairman's Address to Shareholders
|
| 2018-11-23 09:09:00 |
FNA Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ded7c4287396e10e1845f42b1403d5b3 |
|
| 2018-11-30 12:18:00 |
Changes to the Board of Directors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed481c00de40f2d7debd27fff6e05c7f |
Director Appointment/Resignation
|
| 2018-12-04 09:21:00 |
Successful Delivery of CRIPR/Cas9 into Cells ex vivo |
1 |
https://app.sharelinktechnologies.com/announcement/asx/010c532ecb47b66c71756f4c0e8385d0 |
|
| 2018-12-04 18:50:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8bc58f00bf752a0532eedd635622a5e1 |
|
| 2018-12-04 18:57:00 |
Notice of Change of Interest of Substantial Holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fef499971ae4d2923795abc599e68cc5 |
Change in substantial holding
|
| 2018-12-04 18:57:00 |
Director Interests Notices - Appendices 3X,Y and Z |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8c4629a0741a2fc8edc96a0025454445 |
Initial Director's Interest Notice
Change of Director's Interest Notice
Final Director's Interest Notice
|
| 2018-12-06 16:08:00 |
In vivo success - peptide vaccine in Herpes Simplex Virus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/22cd76350cc940f50d8d8bff7042e29e |
|
| 2018-12-06 17:20:00 |
In Vivo Success - peptide vaccine (Amended Graphics) |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e3f6006ee719ef4d2a97b989bbb16a45 |
|
| 2018-12-07 18:18:00 |
Section 708A Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/457f7829eeb6695fa6b872b8160f370e |
|
| 2018-12-24 12:19:00 |
Executive Team Change |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04a71bb6550a8245faa63ca070cb795d |
Company Administration - Other
|
| 2019-01-17 08:22:00 |
CEO letter and Operational Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c82ca1f018cdf94ed5d5c2edae956d44 |
|
| 2019-01-22 12:08:00 |
Conference Presentation - Keystone Symposia Vancouver |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ff8bf5cd20eb24ba3752d05cb212a54 |
|
| 2019-01-31 14:11:00 |
Dec 2018 Operational Update and App4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56f6bfaf5065a223a31dfce497a06c56 |
Commitments Test Entity - Second Quarter Report
|
| 2019-02-08 11:17:00 |
First Competitive Read Out - Peptide Vaccine |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b7525d2c59a5878feff53ff0df756861 |
|
| 2019-02-11 13:35:00 |
Director Resignation and App3Z |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b4b1c97d19a803b11d09daf2777f9c30 |
Final Director's Interest Notice
Director Appointment/Resignation
|
| 2019-02-28 13:31:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0cd421f97fb5d18c776be37e9a8ecb28 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2019-03-12 09:45:00 |
Flagship Program - Successful Animal Models |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7c27ac172fd60521fb1fbeb1bb6f270b |
|
| 2019-03-14 09:28:00 |
Collaboration Agreement - siRNA delivery |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bd7f09aae15d729074595cb70542830b |
|
| 2019-03-22 08:21:00 |
Scientific Advisory Board Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a260908d93e82bd15b29ccb9b9dd972 |
Company Administration - Other
|
| 2019-04-24 13:16:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c839c33042f9d257c664dbccc8dc451c |
Change of Director's Interest Notice
|
| 2019-04-29 14:04:00 |
March 2019 Quarterly Operational Update and App4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0fe7b5660be8ba26f05df1c2f1603c6e |
Commitments Test Entity - Third Quarter Report
|
| 2019-06-27 08:57:00 |
Break Through Animal Model Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a64103a46f4080ff109a724b1398e4bd |
Company Administration - Other
|
| 2019-07-23 09:37:00 |
Animal Models - 400% Outperformance of Gold Standard |
1 |
https://app.sharelinktechnologies.com/announcement/asx/352e24f434ddd774da88d96204454d90 |
|
| 2019-07-23 18:32:00 |
Operational Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b5e3e8e8a80a5de1cbcf86001599dbea |
Commitments Test Entity - Fourth Quarter Report
|
| 2019-07-24 09:13:00 |
Company Presentation - July 2019 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f7d4ccdf8bd8364d1ae239f8d1c001e3 |
|
| 2019-08-06 09:41:00 |
Phylogica's Technology is Effective in Human Cells |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4a611b700155fe54c9cec520e5f3507b |
|
| 2019-08-07 18:21:00 |
Response to ASX Aware Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d58510fc306be9efa844f48fe38ecc46 |
|
| 2019-08-09 14:08:00 |
Company Re-branding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/525e2e17222224685f6adeb9714e770e |
Company Administration - Other
|
| 2019-08-22 10:06:00 |
Successful Time - Course Studies in Animals |
1 |
https://app.sharelinktechnologies.com/announcement/asx/697d637eb22b15a95b355858fefabcc7 |
|
| 2019-08-23 09:04:00 |
Investor Call |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59e9b51982838db12f0a514d3a57a3d2 |
|
| 2019-08-30 12:01:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a0f6cc10cf7d7dba34a992fa1e2e56f5 |
|
| 2019-09-03 08:21:00 |
Successful Competitive Drug Evaluation in Animals |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ded824c26737eb6bd799e12cb767ade |
|
| 2019-09-04 11:20:00 |
Investor Relations Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5402cdddc099a52a26569ed2461a9671 |
|
| 2019-09-13 09:14:00 |
Scientific Advisory Board Appointment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03af9b1ebbeb13bf8ea98b8cee4366a7 |
Company Administration - Other
|
| 2019-09-17 15:20:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0638293e345fdb5b898607fb0771c7bf |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2019-09-25 10:50:00 |
Successful Time-Course Studies in Animals |
1 |
https://app.sharelinktechnologies.com/announcement/asx/afb38fdf4496e8cee588d20d886596c2 |
|
| 2019-09-30 09:11:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d7d9b5e9693f85447314b815a14538e1 |
|
| 2019-10-01 10:02:00 |
Strategic Partnership and Lead Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a130c825347ba0fcf8f9777bcb4b6bfd |
Company Administration - Other
|
| 2019-10-09 09:33:00 |
Successful Major Milestone - Human Retina in a Dish Models |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f727227fba8b553f141afbb5a9d2c97 |
|
| 2019-10-14 11:04:00 |
Presentation Oligonucleotide Therapeutics Society Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dcedac8de4354d46296a23ec998c2460 |
|
| 2019-10-15 10:24:00 |
Investor Relations Presentation - October 2019 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c10269419c512e1da8ae3cadd8c8ca74 |
|
| 2019-10-18 16:46:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8110cba3d14524cc4bcd4476c85a5dd9 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2019-10-18 16:46:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce36293edc8efab2488ea90a154f37ca |
Notice of Annual General Meeting
|
| 2019-10-18 16:47:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8aecee2f3beb89a592de7130a9f6ad9e |
|
| 2019-10-21 17:01:00 |
Coprporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/933cded7ffc0e1e6030ea35e7191bb41 |
|
| 2019-10-30 17:12:00 |
Sept 2019 Quarterly Shareholder Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8166f6b5b810befba5e7a9b329f190f6 |
Commitments Test Entity - First Quarter Report
|
| 2019-10-31 09:34:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5535e82585bec321f5815f602bc40179 |
|
| 2019-10-31 10:06:00 |
$26.8m Fully Underwritten Accelerated Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/26b0eb4e1d4bf4935a0913e66ab95a75 |
|
| 2019-10-31 10:07:00 |
Notice Under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/21b89e1ad015cd7d042f2b31774c0f17 |
|
| 2019-10-31 10:07:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec199b2a72c6ba75de1e3aed82298a8b |
|
| 2019-10-31 17:06:00 |
Entitlement Offer - Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/42bd5d78319c0eb4c92d3d00f15b5b04 |
|
| 2019-11-04 09:30:00 |
PYC's Institutional Entitlement Offer Closes |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98708cbac5da2cdea5c42d30343b3383 |
|
| 2019-11-04 09:30:00 |
Retail Offer Document |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1cd2941272d086e99f9d10044d6dcb53 |
|
| 2019-11-07 16:56:00 |
Despatch of Retail Offer Document |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f33978c147515b2c22573886bf178c2 |
|
| 2019-11-07 16:57:00 |
Letter - Ineligible Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af2fc3a2a3edb8ac9a18ac7347f460f8 |
|
| 2019-11-08 09:44:00 |
Appendix 3B - Institutional Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9bb3b2b8bfb502c815cfd410abb2871c |
|
| 2019-11-11 16:56:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b56f7f3fd1bf5812bfd67f5fd14dec59 |
Change in substantial holding
|
| 2019-11-12 18:57:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de736142de0b54c061f88d57bf55deb7 |
Change of Director's Interest Notice
|
| 2019-11-12 18:57:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88cd2644f00de862ae9fc414c941e682 |
Change in substantial holding
|
| 2019-11-14 08:24:00 |
PYC Increases Shareholding in Vision Pharma |
1 |
https://app.sharelinktechnologies.com/announcement/asx/17f4706b8390b0c9bc901910289f1925 |
|
| 2019-11-15 08:22:00 |
Conclusion of Genentech Antimicrobial Collaboration |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4c62d54a89fa156d42121f9b92a4f7d5 |
|
| 2019-11-21 09:04:00 |
Completion of Retail Entitlement Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c048326cab7b5844f5896297b838928 |
|
| 2019-11-21 09:23:00 |
2019 AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4435348dcc2aff9b5d5c51007e4b8d11 |
|
| 2019-11-21 09:26:00 |
2019 AGM Chairman's Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/437ae7a8a5e375b67554f30915aaf3dc |
Chairman's Address to Shareholders
|
| 2019-11-21 15:40:00 |
Results of 2019 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/51c57c1ce492d1bd07a3a370406ca8e2 |
|
| 2019-11-27 14:22:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1e5597917ba3deac3c2b5c9d4ab39e2 |
Change in substantial holding
|
| 2019-11-28 20:07:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b21c839c3b8b5379b802a6d7699463f7 |
|
| 2019-12-02 08:48:00 |
Drug Delivery Greater Than 100% More Effective In Animals |
1 |
https://app.sharelinktechnologies.com/announcement/asx/47b72c8b96ee4266119810a8f89be906 |
|
| 2019-12-02 12:30:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb8ad1bcbbe5143ed9c36ed36dbbca52 |
Ceasing to be a substantial holder
|
| 2019-12-02 16:33:00 |
Change in Director's Interest Notices x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16eea24e2a94ce1913193fd5bbdddc95 |
Change of Director's Interest Notice
|
| 2019-12-02 16:34:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ea9950b349e9094b28ed0de75cffbd7 |
Change in substantial holding
|
| 2019-12-02 16:35:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2baff91957ce07b0c6cdd0df8880ba11 |
Change in substantial holding
|
| 2019-12-05 13:46:00 |
Drug Delivery Greater Than 100% More Effective - Amended |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c406000224e725590a53da3b44ea9de1 |
|
| 2020-01-06 09:48:00 |
Quarterly Shareholder Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2a4167ae69a1f34d31240d3b4f816a1e |
|
| 2020-01-20 09:25:00 |
Change of Share Registry |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5c4d28f8b3e941cbe86b17f1e7d193b |
Details of Share Registry address
|
| 2020-01-31 12:18:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/08f223fec3c93952418e3746e968f58d |
Commitments Test Entity - Second Quarter Report
|
| 2020-02-03 10:09:00 |
Expansion Of Drug Development Pipeline |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4024e26119581b095d7c563d3d80b97c |
|
| 2020-02-05 13:55:00 |
Investor Call 27 February 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b774592cde229c25107cb75674c4d60b |
Company Administration - Other
|
| 2020-02-12 16:03:00 |
CEO Appointment and Establishment of US Office |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c76abaea3ba9deb1b2be4a68d4195bca |
Director Appointment/Resignation
Company Administration - Other
|
| 2020-02-12 16:04:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a14b07a7a8be7cc3398f58aae3949dd5 |
Initial Director's Interest Notice
|
| 2020-02-17 12:24:00 |
NHMRC grant for identifying new antisense drugs |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e56e4efc76373ae3e7983e6498969266 |
|
| 2020-02-19 13:20:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa992993cfc95863d5116566ff33bf34 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2020-02-24 10:21:00 |
Investor Presentation - February 2020 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/db9e3518aebfecd7802a3763eb60e4d5 |
|
| 2020-02-28 14:24:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/202c0057fa46447c00321173d2e50396 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2020-03-18 18:32:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cbf97eaaaffce08cc1fdf6c60d468fc |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2020-03-20 17:38:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c4b3d27a286ee3a6b06d1dec3142855 |
Becoming a substantial holder
|
| 2020-03-30 09:19:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4fb72a910e24f2c87f6a42c95af76c3c |
|
| 2020-03-30 17:16:00 |
Investor Call 9.00am AWST Wed 1 April 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c409a1eac209c0d0e89b86aca01d96d |
|
| 2020-04-01 10:01:00 |
Successful Efficacy Result on Path to First in Human Studies |
1 |
https://app.sharelinktechnologies.com/announcement/asx/78463a69255db0e3be87ec127b9b69b4 |
|
| 2020-04-01 11:24:00 |
Investor call 12.00pm AEST Wednesday 1 April 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/189a640cc31b78ee39aaa18cfd4a3e14 |
|
| 2020-04-08 09:30:00 |
Successful Toxicity Results Confirm Safety Advantage |
0 |
https://app.sharelinktechnologies.com/announcement/asx/571e320b7345ea758012b12870486c22 |
|
| 2020-04-15 10:02:00 |
Efficacy and Toxicity Studies Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f40c9f7f1d553c1ba3b322aca8df006b |
|
| 2020-04-29 10:57:00 |
March 2020 Quarterly Activities and Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/70cad88d08e06efc6538876a7757c1fb |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2020-05-25 10:27:00 |
World Class Results - Lions Eye Institute News Release |
0 |
https://app.sharelinktechnologies.com/announcement/asx/295f9f4c68ab53e976a5684b423f8a52 |
|
| 2020-06-04 18:52:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca7a563f2631bb99d27a1accbdb0e5a2 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2020-06-09 08:43:00 |
PYC Recruits High Profile Chief Medical Officer to US Ops |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f80dc24db35c2ac1d7d2f08257a02f8b |
Company Administration - Other
|
| 2020-06-12 08:16:00 |
S&P DJI Announces June 2020 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0d1b3ff5ef853e83fb2e82b246397eeb |
Standard and Poor's Announcement
|
| 2020-06-16 13:24:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16e5481757d16ef6687154cedae4bd02 |
Change in substantial holding
|
| 2020-06-16 13:25:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64f7077f585243bfee7075f00c700c57 |
Change in substantial holding
|
| 2020-06-16 13:29:00 |
Change of Director's Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b943974df0dc0c72a9dfbf1bee509e0e |
Change of Director's Interest Notice
|
| 2020-06-22 09:32:00 |
Investor Presentation June 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d77c1fbf4b4b1a989bbaee99d29ebd0 |
|
| 2020-06-30 09:23:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d49526c17aa3deff45217937a54bf15e |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2020-07-09 11:25:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84b45240de7b94cc19880f93d1157ebd |
Appendix 2A (Application for Quotation of Securities
|
| 2020-07-22 09:20:00 |
Successful Dose Response & Toxicity Studies in Lead Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d9fd3878bc2f4df83f8f69704f5af16c |
|
| 2020-07-30 14:39:00 |
June 2020 Quarterly Activity Report and Cashflow |
1 |
https://app.sharelinktechnologies.com/announcement/asx/21b98030f2ed5bf9794e77797ca7241c |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2020-08-03 10:06:00 |
Investor Call - 8am AWST - Wednesday 12 August 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0de4d1f7dca1cf1d30e214c466680ce4 |
|
| 2020-08-05 09:38:00 |
Shareholder Update - Forward View 2020 Milestones |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6244e708d485cc8663dada6f6cb38437 |
|
| 2020-08-14 08:32:00 |
Shareholder Update August 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ac07e2d4f4982407dc216fb0798fc83 |
|
| 2020-08-19 13:15:00 |
Executive re-structure across global operations |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c8cbc46588980ee72c9fc808e434ec5 |
Director Appointment/Resignation
Company Administration - Other
|
| 2020-08-19 13:38:00 |
Appointment of world-renowned Chief Scientific Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ef26a53c90658df7934358328744588 |
Company Administration - Other
|
| 2020-08-31 17:21:00 |
Appendix 4E Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/41cbd9a5c2a7a36535ff55c724ca1bdd |
|
| 2020-09-08 09:23:00 |
Creation of Novel Gene Therapy Delivery Technology |
1 |
https://app.sharelinktechnologies.com/announcement/asx/15a319e0c40e33218bc2bc2d5ffacce3 |
|
| 2020-09-14 16:27:00 |
Annual Financial Statements June 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b467d0076a79670bd35acfe2b64ce7d |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2020-10-05 08:20:00 |
Second Potential Blockbuster Drug Added to PYC's Pipeline |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e9bee66bc213b60e530ac308ba50fe94 |
|
| 2020-10-05 18:04:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3eb68183876570acf373b55e79d791a9 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2020-10-05 18:05:00 |
Corporate Governance Statement and Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c72d51cd07c2ac91f1eb6b5666ca594 |
|
| 2020-10-05 18:06:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7475f7196a8f7fe922a79143ea43a619 |
Notice of Annual General Meeting
|
| 2020-10-07 08:18:00 |
PYC's Lead Drug Effective in Patient Derived Models Tested |
1 |
https://app.sharelinktechnologies.com/announcement/asx/705b6c8141512d8d1876cad6e088a588 |
|
| 2020-10-09 12:47:00 |
Technical Presentation - October 2020 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d80ba5755d31c00e463aad3338e4172 |
|
| 2020-10-09 18:29:00 |
Investor Call 15th Oct 2020 12pm AEDT 9am AWST |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d81917becaadf3bafc9651def2ea655 |
|
| 2020-10-09 18:29:00 |
Cancellation of Unlisted Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2abf99c5faca473de2c6aafecf6d969 |
|
| 2020-10-09 18:29:00 |
Notice of Directors intention not to seek re election at AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/057ff805be31c6d67d44164ba8fce73f |
Director Appointment/Resignation
|
| 2020-10-12 08:16:00 |
New Drug for Substantial Unmet Need Added to Pipeline |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8d067efc5e3091b8d757943e825d83ce |
|
| 2020-10-16 09:15:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/695f5da2463d71cb4d34e0c9127c61a9 |
|
| 2020-10-20 09:40:00 |
Cleansing Notice Under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1eeef5ccd50476d50980044a8b30ff78 |
|
| 2020-10-20 09:45:00 |
PYC Business and Equity Raising Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/371a7dcd5e41802ff1bff2b234d0440a |
|
| 2020-10-20 09:45:00 |
Proposed issue of Securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7c0fd989eaa930e1b358d5b58f5f228 |
|
| 2020-10-20 09:45:00 |
PYC Equity Raising to Raise up to $55 Million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/66e51b97c9bd6439a0d47d170a8572c4 |
|
| 2020-10-22 09:53:00 |
Successful Institutional Entitlement Offer and Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f5099114fe3f07abeb522391021d4286 |
|
| 2020-10-23 12:25:00 |
FDA Response to Orphan drug Designation Request |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0242cd284fd59694b9a4b946256f1a58 |
|
| 2020-10-26 17:29:00 |
Dispatch of Retail Offer Document |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abc3779a58d258c8ccd2124fcb427478 |
Company Administration - Other
|
| 2020-10-26 17:32:00 |
Dispatch of Notice to Ineligible Retail Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aefb1bfa69f30e179cfc89b193c8872b |
Company Administration - Other
|
| 2020-10-26 20:24:00 |
Review of Activities and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/01880e51aee1a396d75231bfd0643008 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2020-10-27 11:26:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/00fd610cd9a2da38ffd6a31789e393f1 |
Appendix 2A (Application for Quotation of Securities
|
| 2020-10-28 16:36:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/52bad7edd3b4c8096b99cbcb1f736827 |
Change in substantial holding
|
| 2020-10-28 16:37:00 |
Change of Director's Interest Notice x 2 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec2c01e60510f60e486b8759718d2117 |
Change of Director's Interest Notice
|
| 2020-10-28 17:42:00 |
Notice under Section 708(A) |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54d09a57b7f177b71f972b62e9fd0a26 |
|
| 2020-10-29 08:04:00 |
Grants Awarded to Support Clinical Progression of Lead Drug |
0 |
https://app.sharelinktechnologies.com/announcement/asx/223936c6e331b8e037dc3e9820ce05d3 |
Company Administration - Other
|
| 2020-11-06 10:58:00 |
AGM Chairman's Address and CEO Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ff6a8405efb7d21be26298f794a222c |
Chairman's Address to Shareholders
|
| 2020-11-06 15:47:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a96a4be27d9735e0ddcc84b55c7e1e30 |
|
| 2020-11-06 15:48:00 |
New Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8ce9bd29313b94e930c1ccf791c4139 |
|
| 2020-11-10 12:58:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1930f78fbde149acaa58e86fb0c660d8 |
Final Director's Interest Notice
|
| 2020-11-13 12:29:00 |
Completion of Retail Entitlement Offer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6320850b4673a815a8d4e5148b0d2b61 |
|
| 2020-11-18 11:01:00 |
Retail Entitlement Offer Share Issue and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f93b2ba5d943c8bebf40a33e7c952fb |
Appendix 2A (Application for Quotation of Securities
|
| 2020-11-18 16:47:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a34b9d1a09ffb1916810fdf62230c725 |
Change in substantial holding
|
| 2020-11-25 08:59:00 |
PYC to Present at the Evercore ISI Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/14ae2af13b9eadc4a107e2a607e1620a |
Company Administration - Other
|
| 2020-12-10 10:51:00 |
Appointment of Chief Executive Officer in the United States |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a534bf41356108803ae05a3e1b36d1d5 |
Director Appointment/Resignation
Company Administration - Other
|
| 2020-12-14 09:31:00 |
Letter to Shareholders from the US CEO |
0 |
https://app.sharelinktechnologies.com/announcement/asx/16745d18d4eb29b56618044e87702875 |
|
| 2020-12-16 09:38:00 |
Visual Evidence of Lead Drugs Efficacy |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fd3d566e6581b180aaf98abe837f96ea |
|
| 2020-12-16 17:41:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4f8a2fc54a70ce621eff585e99180ad2 |
Initial Director's Interest Notice
|
| 2020-12-16 17:43:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa3569901e28b6e5546b9c7d30c942e0 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2021-01-06 10:26:00 |
PYC to Present at ICR Westwicke Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c08995e5bb99b20d6b49b71cb23128b |
Company Administration - Other
|
| 2021-01-14 10:32:00 |
ICR Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/236e1692ab9f6fc1ce2e181b344b344f |
|
| 2021-01-29 17:47:00 |
Quarterly Activities Report and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cab8bf267fc465dc8526f156f22698e9 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2021-02-11 09:42:00 |
PYC to Participate in RNA Discussion - CEO BIO Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f0c6d23607eb337b034fd02c60f5131 |
Company Administration - Other
|
| 2021-02-19 19:41:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e68ab827961d4d89d15e675cd32facc4 |
Change of Director's Interest Notice
|
| 2021-02-22 09:44:00 |
Progress US Clinical Stage Company and Corporate Objectives |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a4bfa323728d80a9166f5361a55e7815 |
|
| 2021-02-23 09:38:00 |
PYC Expands US Executive Leadership Team |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d0ea39dd8072b58701cc582052c73e17 |
Company Administration - Other
|
| 2021-02-26 17:05:00 |
Half Year Accounts and Appendix 4D |
1 |
https://app.sharelinktechnologies.com/announcement/asx/69ac1ff1b6e2f1545f959a590c07f5a0 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2021-03-02 08:21:00 |
Lead Investigational Drug Demonstrates Key Improvement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ee0cd3c0d51630c144455e81befc01c8 |
|
| 2021-03-17 10:10:00 |
PYC Appoints US Biotech Veteran to its Board of Directors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ffa0256259a827497519e47160c5bb8f |
Director Appointment/Resignation
|
| 2021-03-22 08:17:00 |
Participation in SVB Leerink Biopharma Private Co Connect |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ff78054c5232877f0a95add5725f84e |
Company Administration - Other
|
| 2021-03-23 18:46:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8ad6a237f4beba4e48dd24c72f0418ea |
Initial Director's Interest Notice
|
| 2021-03-25 20:02:00 |
Appendix 3G - Issue of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cdc4305103e026c9133cb605282d20dc |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2021-03-26 09:48:00 |
Director Retirement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/474c70fef94765226b934033d39e42ff |
Director Appointment/Resignation
|
| 2021-03-29 10:54:00 |
PYC Appoints U.S. Biopharma Exec Jason Haddock to its Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b297c066754425faeeb75378360fbe3 |
Director Appointment/Resignation
|
| 2021-03-30 20:12:00 |
Appendix 3G - Issue of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1c6938acbd870737272a217f7e7cf67a |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2021-03-30 20:13:00 |
Appendix 3X - Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9c3247811576f07a629706006aedc9b |
Initial Director's Interest Notice
|
| 2021-04-06 08:17:00 |
Quarterly Investor Call - 15th April 2021 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03573be6635c8f78c085ac2009c9b22a |
|
| 2021-04-12 08:16:00 |
Preclinical Data - Superior PPMO Delivery to the Brain |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f80b1738f5eb6a6d5555d7dad527d4d0 |
|
| 2021-04-15 09:26:00 |
April Investor Call Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f71807f23673e0a7f95d4670997ad6c7 |
|
| 2021-04-22 09:31:00 |
Corporate Presentation April 2021 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/015c14e2d28b50fa6f33ad33bfdc0286 |
|
| 2021-04-30 08:45:00 |
March 2021 Quarterly Report and Cashflow |
1 |
https://app.sharelinktechnologies.com/announcement/asx/083751e106e6aedf4b13b19d29b70c7f |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2021-05-03 08:15:00 |
Set To Announce Efficacy Results For Second Drug Program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d434b5a3ee2e1a0eaa4799769d83c7d |
|
| 2021-05-04 08:22:00 |
PYC Invited to Present at ARVO 2021 Annual Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/70d98dbd6ba71a89ca3f8329d89348ce |
Company Administration - Other
|
| 2021-05-18 08:23:00 |
SECOND DRUG PROGRAM - EFFICACY DATA IN PATIENT CELL MODELS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c27f9089a47c69d9e0a0e4b5540b4f9 |
|
| 2021-05-26 08:22:00 |
Evercore ISI GenomeRx Emerging Therapeutic Company Day |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ceb6e14e42a5b4edacf5ac01d3211d70 |
Company Administration - Other
|
| 2021-06-07 09:31:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f848b277e7f3adc917c3d03dba11c486 |
|
| 2021-06-08 09:51:00 |
Second Drug Program Progressing Towards Human Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1422fdca77885923ebc012da9b066866 |
|
| 2021-06-15 08:46:00 |
New U.S. Headquarters, and Residency at JLABS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9953eee16f890f0335ae1e0e494b5504 |
Company Administration - Other
|
| 2021-06-15 18:30:00 |
Application for quotation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/654dcfc3d023880481621438a8eb068b |
Appendix 2A (Application for Quotation of Securities
|
| 2021-06-15 18:32:00 |
Exercise of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/659c3759b6dca7e6e6e1368f0749a00c |
Change of Director's Interest Notice
|
| 2021-06-29 08:20:00 |
VP-002 Program - Technical Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69baeb54493315bb0e37dfaf44804a3a |
|
| 2021-07-01 14:41:00 |
Change of Auditor |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ba87af0901eb5fc23f5ae78359f9f02 |
Company Administration - Other
|
| 2021-07-14 08:54:00 |
Commencement of Larger Animal Studies for Lead Program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f821b867cfca9a3bf646d3012c27c4da |
|
| 2021-07-28 08:49:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4f70b78e5fbc74a1f278a764f158e0a7 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2021-08-03 08:21:00 |
Participation in Upcoming U.S. Investor Conferences |
0 |
https://app.sharelinktechnologies.com/announcement/asx/777918619ac122c5be45cd55dadf6c4f |
|
| 2021-08-11 08:56:00 |
PYC Quarterly Investor Call - August 17 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6be6426a12d2da96d6e9f2e7b2f7acf |
|
| 2021-08-17 08:43:00 |
Ophthalmology-Focused Clinical Advisory Board |
0 |
https://app.sharelinktechnologies.com/announcement/asx/49c802750eb1645faf90cc193784aa54 |
|
| 2021-08-17 08:45:00 |
August Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f889c15d4edeb2ceb4d4aed337e8e3c0 |
|
| 2021-08-31 17:29:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1af2fadc83b7b5ca1434f8d50acb68eb |
|
| 2021-09-15 08:49:00 |
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cc6d3fba1922123658c4199ac17ca5c |
Company Administration - Other
|
| 2021-09-21 10:50:00 |
Upcoming Poster Presentations at TIDES USA and OTS 2021 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f77593a5002865491c27bfbeb0875355 |
Company Administration - Other
|
| 2021-09-22 17:56:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7998fa25fbe12a3307e0fbcac2fc1762 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2021-09-22 17:57:00 |
Corporate Governance Statement and Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ab9c2c08bdb88a8eda4db3432998f79 |
|
| 2021-09-29 09:44:00 |
Retina Target Engagement Confirmed in Large Eye |
1 |
https://app.sharelinktechnologies.com/announcement/asx/03455a335f7d2e0960378036f5bf9672 |
|
| 2021-10-19 16:50:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5fd3460ac7d5cba3b249c1709a9a306e |
Notice of Annual General Meeting
|
| 2021-10-28 09:15:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e23df2f65482ae7b0c5c1736f6a5bf6d |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2021-11-15 09:27:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3cdfbbb6c7a6860a58f7a0f5ab67bbe9 |
|
| 2021-11-16 10:05:00 |
Successful Completion of Key Translational Milestone |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a24d94e2adddb9932cc8721874a25e39 |
|
| 2021-11-17 10:37:00 |
Annual General Meeting - Conference Link |
0 |
https://app.sharelinktechnologies.com/announcement/asx/72003b69374bcf97db983af4a3eb59a3 |
Notice of Meeting - Other
|
| 2021-11-18 10:03:00 |
2021 AGM Chairman's Address and CEO Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c24ec5f840db4f7e29039d11d0ec97a6 |
Chairman's Address to Shareholders
|
| 2021-11-18 17:08:00 |
Results of 2021 Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e15e661512406a1626b247746b14b7f8 |
|
| 2021-11-25 13:56:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/033132715eced2e01b510458ef87fb56 |
Final Director's Interest Notice
|
| 2021-11-29 17:27:00 |
Notification of cessation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f3f0973f83a93a70fd5b39913cab8f70 |
Appendix 3H (Notification of cessation of securities)
|
| 2021-11-30 13:54:00 |
Notification regarding unquoted securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1e8a4f520635f7fe7871111339c4e3ae |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2021-11-30 14:01:00 |
Appendix B Terms and Conditions of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/617621302da4bfa6c2309c1d0caaccbc |
|
| 2021-11-30 14:01:00 |
Appendix A Terms and Conditions of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f60cb0b0fcce39d3223daab15f2d3536 |
|
| 2021-11-30 14:02:00 |
Appendix C US Sub Plan |
0 |
https://app.sharelinktechnologies.com/announcement/asx/24447d1240229d0eafde779ed5594a5e |
|
| 2021-12-09 08:20:00 |
Notification of cessation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2d30e9992322c9a7aeebe9ab3f7a28d7 |
Appendix 3H (Notification of cessation of securities)
|
| 2021-12-20 14:56:00 |
Change of Registry Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/87b28bf8ddb22b7377d32980f71c00fe |
Details of Share Registry address
|
| 2021-12-29 13:46:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f6c8ec57ecca5186cae37bf0bf76ea38 |
Change in substantial holding
|
| 2022-01-07 14:45:00 |
Notification of cessation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a04de98b53c674b111f0622deec9c35f |
Appendix 3H (Notification of cessation of securities)
|
| 2022-01-27 09:54:00 |
Quarterly Activities and Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/17dec2406e07e0597a8f6ab02f965d98 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2022-02-02 17:16:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f045fd929833633d290c643eb3bb31c |
Becoming a substantial holder
|
| 2022-02-17 09:17:00 |
PYC Increases Shareholding in Vision Pharma |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9cdf5dc7cd4bd5f9a8b2c8f09c1f4a1a |
|
| 2022-02-28 19:35:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d1c1fb2e6379669b16d7244d4d706f5c |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2022-03-01 17:20:00 |
Notification regarding unquoted securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/694b418f0c1d736bf35118615864e760 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-03-08 12:12:00 |
Quarterly Investor Call March 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f97e9444a7b817d503ac7b3761ff7b68 |
Company Administration - Other
|
| 2022-03-17 09:24:00 |
Q1 Investor Call Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd0634f0d1cd9ad29bb9497110044dc4 |
|
| 2022-03-23 12:13:00 |
Completes FDA Pre-IND engagement - RP11 program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c927ef6fa9e8b946e211730f13ad7c33 |
|
| 2022-04-29 09:26:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/48561980f8e83e3264ee0bf82d2b7563 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2022-05-04 15:07:00 |
Issue of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/94466677678a1f4430ef611944cacc46 |
|
| 2022-05-04 15:10:00 |
Notification regarding unquoted securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5f30b5210a775880a173eae99fd94d1a |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-05-04 15:11:00 |
Appendix A Terms and Conditions of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6644394f2e82b671814b3d93f4224431 |
|
| 2022-05-10 08:37:00 |
PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b64ae7cf4d0d14ff9f08e2eb39636609 |
|
| 2022-05-27 11:43:00 |
PYC Q2 Investor Call - 31 May 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1053579496053fda489c3b99f994811d |
|
| 2022-05-31 08:15:00 |
Corporate Presentation - May 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20e508dbbfad56892c1d73f357a1e9e8 |
|
| 2022-06-28 18:15:00 |
Share Trading Policy |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61f2d77086fbbb8867ae280d143d5cea |
|
| 2022-07-27 08:22:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/840e18c27ab677114ebf5f27889e2db6 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2022-08-04 11:26:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a9376eca9719f665385634ec5370fe79 |
Change of Director's Interest Notice
|
| 2022-08-09 10:09:00 |
PYC Therapeutics Investor Call - 18 August 2022 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/caa90603813a2f35ca75bdb82015aa5b |
|
| 2022-08-11 11:58:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/085c352a6f0b10a7b3968d151f7d0a01 |
Change of Director's Interest Notice
|
| 2022-08-18 09:30:00 |
PYC Shareholder Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0762e2899b08cec8cc3097a7da65693 |
|
| 2022-08-31 08:53:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0e802d58a30be6be3abeb4ca62eac60f |
|
| 2022-09-23 08:57:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/69e0a13c86e706727711a32062164da6 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2022-09-23 08:57:00 |
Corporate Governance Statement and Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a6e4d37ffcd6fb042766990121671552 |
|
| 2022-09-27 08:29:00 |
Central Nervous System Drug Program Added to PYC Pipeline |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8b1ae6d5d95e361fe115b01a383a315a |
|
| 2022-10-03 12:52:00 |
PYC Presenting on Drug Delivery Platform at OTS 2022 Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/23ed60c548ed42b0a62855020ad7ba10 |
Company Administration - Other
|
| 2022-10-14 18:31:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/68b7f421b0a692a9dff383b70ed3be9e |
Notice of Annual General Meeting
|
| 2022-10-28 19:12:00 |
Notification regarding unquoted securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d1a3b6569649de103c138b9439896adb |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-10-28 19:12:00 |
Issue of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6a3edd1e3b74ee85e6a77adac22462ed |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2022-10-31 08:06:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e6d47baf8f30aa30d2de7608e9c9872 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2022-11-07 08:21:00 |
Successful Toxicology Studies Pave Way for Human Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f930c7b0678712cc07b629d34cf99ce4 |
|
| 2022-11-21 12:31:00 |
Annual General Meeting - Conference Call |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e81e2b02f2b33809f5356d1f57b2087 |
Notice of Meeting - Other
|
| 2022-11-23 12:32:00 |
2022 AGM Chairman's Address and CEO Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5d4f99aeaa3872f113aed877e8a84a6f |
Chairman's Address to Shareholders
|
| 2022-11-23 15:58:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea0ae5f0656d740fc0a93b0bea34d6a1 |
|
| 2022-11-29 08:24:00 |
PYC Increases Ownership of VP-001 Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/855ef86d816a9af860d7c199d34f7c24 |
|
| 2022-12-21 18:37:00 |
Notification of cessation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bf2b2d6b6c0c0dd999df4b7febda636 |
Appendix 3H (Notification of cessation of securities)
|
| 2023-01-20 08:21:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/27c92a4c62f7173ae85058284c229bbc |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2023-02-02 09:06:00 |
VP-001 IND Lodgement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0904b85a92ddc401567d270808b0876c |
|
| 2023-02-03 11:04:00 |
PYC Corporate Presentation - February 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9accbe5f06a0d1b8a2ab2f12e27cc35 |
|
| 2023-02-10 08:20:00 |
Q1 Investor Call 17 February 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/526566fc487b12c714e74211e67064bf |
Company Administration - Other
|
| 2023-02-15 17:28:00 |
Notification regarding unquoted securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b6e09db1dd66f5597d16db2e58b37cf |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2023-02-15 17:29:00 |
Issue of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9198d81470755fd895b0214015737a40 |
|
| 2023-02-17 08:14:00 |
PYC Investor Update Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/818fc7c74424c18c1f6d746029703417 |
|
| 2023-02-28 17:40:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7898b344aa9ca2b75478b9a8ef9a3506 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2023-03-02 19:57:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/608a61025b4219695c96eb9667475f87 |
|
| 2023-03-06 09:21:00 |
FDA Clears PYC to Commence First Human Trials in RP11 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e95084086d60e847dcad8da8d389d70b |
|
| 2023-03-07 19:48:00 |
Application for quotation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8fba252d8fe44c5fb3ae1ee2e3feac57 |
Appendix 2A (Application for Quotation of Securities
|
| 2023-03-07 19:52:00 |
Cleansing Notice Under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb38c474ebd07b51b70953fae3596dd2 |
|
| 2023-04-03 09:54:00 |
Second Drug Program Progressing to Human Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5a1f3db2e7dcbe38096b7aaf4f3818dd |
|
| 2023-04-19 09:18:00 |
PYC BIO 2023 Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8506213b45a853c48120b8fed93bf617 |
|
| 2023-04-26 08:58:00 |
Commencement of First Clinical Study in RP11 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0056f4d47dcc5740f4a7e49c256b32aa |
|
| 2023-04-28 09:07:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/829df74256cc8efef6b6b8ef1ef30d73 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2023-05-02 08:51:00 |
PYC Presenting at TIDES USA 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c63cf1efa0ebc9758453f76ea7ec37fc |
Company Administration - Other
|
| 2023-05-09 09:18:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c76b0f3e80a9549e085773882bf57084 |
|
| 2023-05-11 10:05:00 |
Proposed issue of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1169693ff8ad23a6601ac8bae376f2b |
|
| 2023-05-11 10:05:00 |
Successful Completion of $30m Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d8e4b37bfd993e7fadb251e40d2a191f |
|
| 2023-05-11 10:05:00 |
Placement Supporting Document |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b2c1b1f57da276f8e5a39b6141950abc |
|
| 2023-05-19 09:43:00 |
Application for quotation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5afd72f8f442e40ce58b0d3f2cc95650 |
Appendix 2A (Application for Quotation of Securities
|
| 2023-05-19 09:46:00 |
Cleansing Notice Under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/282590caa99abde81930d0a313bba825 |
|
| 2023-05-22 17:54:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/185cfbf71bf9cc902bc89aa5b85edb9d |
Ceasing to be a substantial holder
|
| 2023-05-22 17:56:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3bfa9e245e19da40920fc5e2b2c9dbed |
Ceasing to be a substantial holder
|
| 2023-06-01 16:35:00 |
Appointment of Joint Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fd4758bd1d6e99712e9646ee818dce7 |
Company Secretary Appointment/Resignation
|
| 2023-06-02 16:29:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a1b70ce7d45a983ce4d503e03a13fa5 |
Notice of General Meeting
|
| 2023-06-06 09:26:00 |
Phelan-McDermid Syndrome & CNS platform presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/558aa73bdeb66f3538e3f152846715ce |
|
| 2023-06-08 08:21:00 |
Q2 Investor Call 16 June 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4b6e606b54506b61779063940211a46 |
Company Administration - Other
|
| 2023-06-16 08:32:00 |
PYC Investor Update Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20761d985cae4e52ddcdaca2792aa339 |
|
| 2023-06-28 16:46:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/929d298f915ab009737865eafabbfea7 |
Change of Director's Interest Notice
|
| 2023-06-30 08:17:00 |
FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5900556ee1b3a10420759a719f3db6e7 |
|
| 2023-07-04 18:01:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa475ec690b2b04216bf8ac39b520d32 |
Change of Director's Interest Notice
|
| 2023-07-05 16:05:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4c45d89ce004061e0dc1ff2254a7f219 |
|
| 2023-07-10 08:14:00 |
Q3 Investor Call Advance Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/80fe8d82934441d0c776a6f53ffadab3 |
Company Administration - Other
|
| 2023-07-14 16:34:00 |
Application for quotation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a98e06fe984f95b4a6e8490e4660244f |
Appendix 2A (Application for Quotation of Securities
|
| 2023-07-14 16:37:00 |
Cleansing Notice Under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e303aa721cc0608a377125880d987b28 |
|
| 2023-07-14 16:48:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e01b24706de5819fa0603165cd3f9195 |
Change of Director's Interest Notice
|
| 2023-07-14 16:49:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/540015c8573001db31d251e8c4de9e26 |
Change of Director's Interest Notice
|
| 2023-07-14 17:28:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/629ca4bd90ac4ff2806021f3c2446a73 |
Change in substantial holding
|
| 2023-07-18 08:43:00 |
Successful Toxicology Results Pave Way for Phase 2 Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/425686f58506981e2d833ef71192dfe8 |
|
| 2023-07-18 12:53:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/86ce815823fe57ed44d7ecd34a5a677f |
Change in substantial holding
|
| 2023-07-26 09:08:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2cce04463dfe2b9376993803716fdc19 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2023-08-02 08:46:00 |
PYC Receives FDA Fast Track Designation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d466e05c519336454df41be72fccc2a9 |
|
| 2023-08-10 08:15:00 |
PYC Increases Ownership of VP-001 Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b15fe83e8f76b61ce542d0e49c71f5e8 |
|
| 2023-08-17 10:05:00 |
RP11 Clinical Trial Dosing Completed In Patient Cohort 1 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7b7818149c84b0502840a7944844baf0 |
|
| 2023-08-21 18:58:00 |
Notification of cessation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce0b7dcc8f01886a5a899640110392f7 |
Appendix 3H (Notification of cessation of securities)
|
| 2023-08-31 16:42:00 |
Appendix 4E and Audited Financial Statements |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4816110bcfce72230e71aaab0d80ae99 |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2023-09-12 08:16:00 |
E&P Healthcare Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1a3102be51146663153d5040ab6c21d |
|
| 2023-09-19 16:59:00 |
Q3 Investor Call 27 September 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4b33ee6917dfa7fc79f8b8751f1b4302 |
Company Administration - Other
|
| 2023-09-22 09:05:00 |
Safety Review Committee Approves Dose Escalation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1e9bf75237a24dc829f63c231c641fdb |
|
| 2023-09-27 08:41:00 |
Q3 Investor Call Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3600be12474f14015637e9b7c88a4c5c |
|
| 2023-10-04 08:19:00 |
PYC-001 Effective In Both NHPs and Patient-Derived Models |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c093bb3f119d31dced48538edff6f932 |
|
| 2023-10-05 10:01:00 |
Investor Presentation ADOA Program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22d081ac4b4b927ccf1f0de6e4d82e89 |
|
| 2023-10-16 20:04:00 |
Notification regarding unquoted securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06c8fed29d7314398301d0e2dea664fd |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2023-10-20 09:20:00 |
PYC Presenting on PYC-001 Program at OTS 2023 Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9799da998862661881e4a28fe521b6bd |
|
| 2023-10-24 18:59:00 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/36b89a7ff141a62d2fb09f24fdea50dc |
Full Year Directors' Statement
Full Year Directors' Report
|
| 2023-10-24 18:59:00 |
2023 Corporate Governance Statement and Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32f0d5a5c3623d270130417502199de3 |
|
| 2023-10-24 19:00:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28f95d5d92e96d43097084e108a754d6 |
Notice of Annual General Meeting
|
| 2023-10-25 09:27:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f6bd909b675d040d9ff1d37539fd4d76 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
| 2023-10-26 08:36:00 |
Wilsons Drug & Device Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/76410384cec11f66d922f46107216fdd |
|
| 2023-11-03 09:24:00 |
RP11 Clinical Trial Dosing Completed In Patient Cohort 2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f39f495fa7560a3368646a7c46141c76 |
|
| 2023-11-06 09:43:00 |
PYC and FDA Align On Clinical Trial Pathway in ADOA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/51a663789fc691c7f6d22cc5301a900e |
|
| 2023-11-13 08:59:00 |
New Drug For Major Kidney Disease Effective In Human Models |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e78e5462019e0c66d6f13e26183fbd86 |
|
| 2023-11-16 19:14:00 |
Supplementary Information |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9e5a3d8ec408d6420211f06bb8447744 |
|
| 2023-11-17 10:03:00 |
Polycystic Kidney Disease Program Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb1b8e05d15ced2598f38beeaae60a66 |
|
| 2023-11-21 17:08:00 |
Annual General Meeting - Conference Call |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d4755d0dc7681f79bcfc4cc4125f10d9 |
Notice of Meeting - Other
|
| 2023-11-24 09:37:00 |
2023 AGM Chairman's Address and CEO Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/142c72e25321609a480914c3c7f13dbe |
Chairman's Address to Shareholders
|
| 2023-11-24 16:52:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c1e4caeacf6d64f4fc42dd0e5d7a4ef |
|
| 2023-11-30 17:03:00 |
Response to Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ff5758973dc34886334c11871ba02c77 |
|
| 2023-12-01 12:09:00 |
Notification of cessation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfcd57a9d146aaf73646cbf33014a620 |
Appendix 3H (Notification of cessation of securities)
|
| 2023-12-18 09:42:00 |
RP11 Clinical Trial Progressing To High Dose Cohort |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b746b145fe76e4454ed5ae4bcbf54d85 |
|
| 2024-01-02 09:33:00 |
AI Driven Drug Discovery Collaboration with Google Cloud |
1 |
https://app.sharelinktechnologies.com/announcement/asx/36511aa3908540131d7c79fbc1f25470 |
|
| 2024-01-10 18:35:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da8544230d815ee9f1b2dcf197bb8ed3 |
Change of Director's Interest Notice
|
| 2024-01-22 13:25:00 |
Q1 Investor Call 2 February 2024 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f4925ca48f594772bfeaf1cb5edb78d |
|
| 2024-01-25 09:30:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/50f1dba18c671e5183a7f2cfe951aa5d |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
| 2024-02-02 09:20:00 |
Q1 2024 Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d71346246494a3d91e47344eaef5a0c4 |
|
| 2024-02-06 09:36:00 |
Euroz Hartleys Healthcare Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60fd1fb7a5d61b5aa3c037243055beb0 |
|
| 2024-02-16 17:12:00 |
Receipt of $4.5m Collaboration Fee |
1 |
https://app.sharelinktechnologies.com/announcement/asx/efdf2c58f9443829038d945ec64b3087 |
|
| 2024-02-26 19:07:00 |
Change of Registered Office |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bb9a0a154b83378a0e26f6909399fd6 |
Details of Registered office address
|
| 2024-02-28 09:49:00 |
RP11 Clinical Trial - Dosing Completed in Cohort 3 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b4a4fc6d18283ec9904d7b6a949da6dc |
|
| 2024-02-29 17:35:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/20a62f797bb32edfff78464fcabecf34 |
Half Year Directors' Statement
Half Year Directors' Report
|
| 2024-03-14 09:40:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/565562d0ea92f5bdce993a779e590a71 |
|
| 2024-03-14 10:02:00 |
PYC Equity Raising to Raise up to $74.6 Million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ea864a4c9dc0c891f61d2b37b494c189 |
|
| 2024-03-14 10:03:00 |
PYC Equity Raising Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4f34c4a2e5ffef55425fcc3386e1cbfc |
|
| 2024-03-14 10:03:00 |
Cleansing Notice Under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7141a7395c759c64831e565b2faf7580 |
|
| 2024-03-14 10:03:00 |
Proposed issue of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45c691416fef6638c4a4e9d24ea1cac0 |
|
| 2024-03-15 18:08:00 |
Update - Proposed issue of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30e09163722afcefdde169239564d3c2 |
|
| 2024-03-15 18:13:00 |
Amended Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ccf38f13ce21b317d0ffe0af63ae8223 |
|
| 2024-03-18 09:14:00 |
Completion of Institutional Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ba6fd787b5bc4b7e6d3aa5e8bbb91129 |
|
| 2024-03-20 09:06:00 |
Retail Entitlement Offer Booklet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/48154537fb05a5a1f5648f9e9852ceb1 |
|
| 2024-03-20 09:08:00 |
Despatch of Retail Offer Document |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92d432c2c04d8864fb365cb01edaa863 |
|
| 2024-03-20 09:11:00 |
Despatch of Notice to Ineligible Retail Shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1ce7004b0f050692969b2de7697c8c33 |
|
| 2024-03-25 11:09:00 |
Application for quotation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d5aa2cc9a07789ce710d8c6cd90b4d35 |
Appendix 2A (Application for Quotation of Securities
|
| 2024-03-26 16:42:00 |
Notification of cessation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8897ef543e2dfc5ca82c72dbeaecc6eb |
Appendix 3H (Notification of cessation of securities)
|
| 2024-03-28 17:27:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/778da29e1f03eda4e260bd2aab3c2c3d |
Change in substantial holding
|
| 2024-03-28 17:28:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01bbcddfe8f8fd39ecc8a6c068ad3a26 |
Change of Director's Interest Notice
|
| 2024-04-03 17:55:00 |
Notification of cessation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f606907dffb8028d7a05706041864eb4 |
Appendix 3H (Notification of cessation of securities)
|
| 2024-04-10 18:17:00 |
$74.6 Million Extension of Cash Runway |
1 |
https://app.sharelinktechnologies.com/announcement/asx/17192856fd0e6f69a257f6b006317795 |
|
| 2024-04-11 17:10:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dc80710994b33e28d837ded52c1b8480 |
Change in substantial holding
|
| 2024-04-12 11:57:00 |
Application for quotation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee3243aa9bb3a19411d15c606f23d8f3 |
Appendix 2A (Application for Quotation of Securities
|
| 2024-04-15 11:44:00 |
Update - Application for quotation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c8f15f064c6134d1af08bfaf7b584fa6 |
Appendix 2A (Application for Quotation of Securities
|
| 2024-04-17 17:44:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bb67ea8075029a3e424dbcec4132ba3b |
Change in substantial holding
|
| 2024-04-22 09:02:00 |
Kidney Disease Drug Candidate Progressing to Human Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b74eb158469ce9c46df868b47feaa1f9 |
|
| 2024-04-26 09:32:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8157ebfc655b3bda59b4bb6e32301d8f |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
| 2024-04-29 09:29:00 |
RP11 Drug Candidate Progressing to Mid-Stage Human Trials |
1 |
https://app.sharelinktechnologies.com/announcement/asx/90f22e7770c3e6a370f6c8d2a7c768b9 |
|
| 2024-04-30 09:53:00 |
Application for quotation of securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a09a68e17d8e0812725b2f2b3c49c19b |
Appendix 2A (Application for Quotation of Securities
|
| 2024-05-01 09:47:00 |
Q2 Investor Webinar 9 May 2024 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34107b822c8b33990a5259963a25ee08 |
|
| 2024-05-01 16:48:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/345d6e75c2fd3b3bda3844589e57f25d |
Ceasing to be a substantial holder
|
| 2024-05-06 08:56:00 |
Presentation of RP11 Clinical Trial Data at ARVO Conference |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f9dcf8458bdbd6c89f36529abe03e92 |
|
| 2024-05-09 09:31:00 |
Q2 2024 Investor Webinar Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bb4042b1647f8658d7c3508f3a3a7d5 |
|
| 2024-05-14 09:08:00 |
Successful GLP Tox Studies in Second Blinding Eye Disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ecec4a7ba5e3ba9f9527be7d2bc2dfce |
|
| 2024-05-16 09:12:00 |
RP11 Clinical Trial Dosing Completed in Cohort 4 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38701e2284a3d0226776871f4f6b596f |
|
| 2024-05-17 14:02:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/392155aabebb01ff375827ad840d72b9 |
Change of Director's Interest Notice
|
| 2024-05-17 14:03:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6372e1e777d087a959615a4feb96f8ac |
Change in substantial holding
|
| 2024-05-23 17:15:00 |
Notification regarding unquoted securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d67a9538f1d6bbdbb00222e3424f128 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2024-05-23 17:18:00 |
Issue of Options |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0886f5e7cc65f0776486b7a05cd6de6c |
|
| 2024-05-24 08:22:00 |
Small Shareholdings Sale Facility |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7a021fe6f1878d98e9208e4a339b11ca |
Company Administration - Other
|
| 2024-05-24 09:44:00 |
US FDA Grants Orphan Drug Designation to PYC Drug Candidate |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d483c3738d975f83af7f2ab01f5917f |
|
| 2024-06-07 08:44:00 |
PMS Drug Candidate Effective In Human Brain Cells |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cd61eba8ce10f382c9583ce831b05be9 |
|
| 2024-07-01 09:13:00 |
RP11 Drug Candidate Safe and Well Tolerated |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c59fef5a80449a28cf9d46d5e7315a6d |
|
| 2024-07-02 16:40:00 |
Notification regarding unquoted securities - PYC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f57275060d07a6b0ff1393b78f4ddc6a |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
| 2024-07-10 09:06:00 |
Commencement of RP11 Multiple Dose Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2e25b0ab28bfd695204be05709c90f1c |
|
| 2024-07-12 09:33:00 |
Bioshares Biotech Summit Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/90904e927fe6f4e0aa0ea40a2550cc26 |
|
| 2024-07-17 09:29:00 |
Initial Dosing Completed in Cohort 1 of RP11 MAD Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bed33948197174de3a7c3fa0cb7dd47d |
|
| 2024-07-22 09:22:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6196ec70cbf0e5278bd30c8bd2a28d65 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
| 2024-07-23 09:25:00 |
Extension of RP11 Single Dose Study Into Multiple Dose Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad08bf6972ba6dafd1e7c0218b26c44f |
|